Activation	B-protein
protein	I-protein
1	I-protein
-dependent	O
transcriptional	O
activation	O
of	O
interleukin	B-DNA
2	I-DNA
gene	I-DNA
by	O
Ca2+/calmodulin	B-protein
kinase	I-protein
type	I-protein
IV/Gr	I-protein
.	O

The	O
Ca2+/calmodulin-dependent	B-protein
protein	I-protein
kinase	I-protein
(	I-protein
CaMK	I-protein
)	I-protein
type	I-protein
IV/Gr	I-protein
is	O
selectively	O
expressed	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
and	O
is	O
activated	O
after	O
signaling	O
via	O
the	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
(	O
TCR	B-protein
)	O
,	O
indicating	O
that	O
it	O
mediates	O
some	O
of	O
the	O
Ca	O
(	O
2+	O
)	O
-dependent	O
transcriptional	O
events	O
that	O
follow	O
TCR	B-protein
engagement	O
.	O

Here	O
we	O
show	O
that	O
CaMKIV/Gr	B-protein
induces	O
the	O
transcription	B-protein
factor	I-protein
activation	I-protein
protein	I-protein
1	I-protein
(	O
AP-1	B-protein
)	O
alone	O
or	O
in	O
synergy	O
with	O
T	B-protein
cell	I-protein
mitogens	I-protein
and	O
with	O
the	O
p21ras	B-protein
oncoprotein	I-protein
.	O

CaMKIV/	B-protein
Gr	I-protein
signaling	O
is	O
associated	O
with	O
transcriptional	O
activation	O
of	O
c-fos	B-DNA
but	O
is	O
independent	O
of	O
p21ras	B-DNA
or	O
calcineurin	B-protein
.	O

AP-1	B-protein
is	O
an	O
integral	O
component	O
of	O
the	O
nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
(	I-protein
NFAT	I-protein
)	I-protein
transcriptional	I-protein
complex	I-protein
,	O
which	O
is	O
required	O
for	O
interleukin	B-DNA
2	I-DNA
gene	I-DNA
expression	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

We	O
demonstrate	O
that	O
CaMKIV/Gr	B-protein
reconstitutes	O
the	O
capacity	O
of	O
the	O
cytosolic	O
component	O
of	O
NFAT	B-protein
to	O
direct	O
transcription	O
from	O
NFAT	B-DNA
sites	I-DNA
in	O
non-	O
T	B-cell_type
cells	I-cell_type
.	O

These	O
results	O
reveal	O
a	O
central	O
role	O
for	O
CaMKIV/Gr	B-protein
as	O
a	O
Ca	O
(	O
2+	O
)	O
-regulated	O
activator	O
of	O
gene	O
transcription	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

Activation	NULL
Protein	NULL
1-Dependent	NULL
Transcriptional	NULL
Activation	NULL
of	NULL
Interleukin	NULL
2	NULL
Gene	NULL
by	NULL
Ca	NULL
``	NULL
*/Calmodulin	NULL
Kinase	NULL
Type	NULL
IV	NULL
/Gr	NULL
By	NULL
Nga	NULL
Ho	NULL
,	NULL
*	NULL
Martin	NULL
and	NULL
Talal	NULL
Chatila*	NULL
From	NULL
the	NULL
*Division	NULL
of	NULL
Immunology	NULL
/Rheumatology	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
and	NULL
the	NULL
Center	NULL
for	NULL
Immunology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
;	NULL
and	NULL
the	NULL
*Department	NULL
of	NULL
Cell	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Umeda	NULL
,	NULL
$	NULL
-901-87	NULL
,	NULL
Umed	NULL
,	NULL
Sweden	NULL
Summary	NULL
The	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
CaMK	NULL
)	NULL
type	NULL
IV/Gr	NULL
is	NULL
selectively	NULL
expressed	NULL
in	NULL
T	NULL
lymphocytes	NULL
and	NULL
is	NULL
activated	NULL
after	NULL
signaling	NULL
via	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
it	NULL
mediates	NULL
some	NULL
of	NULL
the	NULL
Ca**-dependent	NULL
transcriptional	NULL
events	NULL
that	NULL
follow	NULL
TCR	NULL
en-gagement	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
CaMKIV/Gr	NULL
induces	NULL
the	NULL
transcription	NULL
factor	NULL
activation	NULL
protein	NULL
1	NULL
(	NULL
AP-1	NULL
)	NULL
alone	NULL
or	NULL
in	NULL
synergy	NULL
with	NULL
T	NULL
cell	NULL
mitogens	NULL
and	NULL
with	NULL
the	NULL
p21	NULL
``	NULL
oncoprotein	NULL
.	NULL

CaMKIV/	NULL
Gr	NULL
signaling	NULL
is	NULL
associated	NULL
with	NULL
transcriptional	NULL
activation	NULL
of	NULL
c-fos	NULL
but	NULL
is	NULL
independent	NULL
of	NULL
p21	NULL
``	NULL
or	NULL
calcineurin	NULL
.	NULL

AP-1	NULL
is	NULL
an	NULL
integral	NULL
component	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
transcriptional	NULL
complex	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
interleukin	NULL
2	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
We	NULL
demonstrate	NULL
that	NULL
CaMKIV/Gr	NULL
reconstitutes	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
cytosolic	NULL
component	NULL
of	NULL
NFAT	NULL
to	NULL
direct	NULL
transcription	NULL
from	NULL
NFAT	NULL
sites	NULL
in	NULL
non-T	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
reveal	NULL
a	NULL
central	NULL
role	NULL
for	NULL
CaMKIV/Gr	NULL
as	NULL
a	NULL
Ca**-regulated	NULL
activator	NULL
of	NULL
gene	NULL
transcription	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Ca2+	NULL
signaling	NULL
pathways	NULL
play	NULL
a	NULL
particularly	NULL
important	NULL
role	NULL
in	NULL
lymphocyte	NULL
biology	NULL
.	NULL

Elevation	NULL
of	NULL
free	NULL
intracellular	NULL
Ca	NULL
#	NULL
*	NULL
concentrations	NULL
after	NULL
engagement	NULL
of	NULL
lymphocyte	NULL
antigen	NULL
receptors	NULL
is	NULL
required	NULL
for	NULL
a	NULL
broad	NULL
array	NULL
of	NULL
events	NULL
in	NULL
the	NULL
course	NULL
of	NULL
lymphocyte	NULL
development	NULL
and	NULL
activation	NULL
.	NULL

These	NULL
include	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
of	NULL
developing	NULL
lymphocytes	NULL
,	NULL
induction	NULL
of	NULL
lymphocyte	NULL
proliferation	NULL
and	NULL
lymphokine	NULL
gene	NULL
expression	NULL
,	NULL
and	NULL
activation-induced	NULL
cell	NULL
death	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
identified	NULL
the	NULL
Ca**/calmodulin-dependent	NULL
phosphatase	NULL
calcineurin	NULL
as	NULL
an	NULL
important	NULL
mediator	NULL
of	NULL
Ca**	NULL
signaling	NULL
in	NULL
lymphocytes	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Calcineurin	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
lymphokine	NULL
gene	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
T	NULL
cell	NULL
mitogens	NULL
,	NULL
and	NULL
its	NULL
inhibition	NULL
by	NULL
the	NULL
immunosuppressive	NULL
agents	NULL
cyclosporin	NULL
and	NULL
FK506	NULL
leads	NULL
to	NULL
the	NULL
suppression	NULL
of	NULL
lymphokine	NULL
gene	NULL
transcription	NULL
(	NULL
3	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
calcineurin	NULL
,	NULL
lymphocytes	NULL
express	NULL
other	NULL
Ca	NULL
``	NULL
*/calmodulin-binding	NULL
proteins	NULL
,	NULL
prominent	NULL
among	NULL
which	NULL
are	NULL
the	NULL
multifunctional	NULL
Ca	NULL
#	NULL
*/calmodulin-dependent	NULL
protein	NULL
kinases	NULL
(	NULL
CaMKs	NULL
)	NULL
!	NULL

.	NULL

These	NULL
serine/threonine-specific	NULL
protein	NULL
kinases	NULL
,	NULL
which	NULL
include	NULL
CaMKI	NULL
,	NULL
H	NULL
,	NULL
and	NULL
IV/Gr	NULL
,	NULL
have	NULL
'	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
AP-1	NULL
,	NULL
activation	NULL
protein	NULL
1	NULL
;	NULL
CaMK	NULL
,	NULL
Ca**/	NULL
calmodulin-dependent	NULL
protein	NULL
kinase	NULL
;	NULL
mutants	NULL
:	NULL
constitutively	NULL
active	NULL
CaMKII-y3	NULL
;	NULL
CaMKIV/Gr	NULL
@	NULL
i	NULL
)	NULL
,	NULL
inactive	NULL
CaMKIV/Gr	NULL
;	NULL
CaMKIV/	NULL
Gr	NULL
{	NULL
wt	NULL
)	NULL
,	NULL
wild-type	NULL
CaMKIV/Gr	NULL
;	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
,	NULL
constitutively	NULL
active	NULL
CaMKIV/Gr	NULL
;	NULL
ACaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
,	NULL
double	NULL
mutant	NULL
constitutive/inactive	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyl	NULL
transferase	NULL
;	NULL
NFAT	NULL
c	NULL
,	NULL
cytosolic	NULL
component	NULL
of	NULL
NFAT	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

broad	NULL
substrate	NULL
specificity	NULL
and	NULL
serve	NULL
to	NULL
regulate	NULL
a	NULL
wide	NULL
array	NULL
of	NULL
cellular	NULL
processes	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Of	NULL
these	NULL
enzymes	NULL
,	NULL
CaMKIV/Gr	NULL
is	NULL
of	NULL
special	NULL
interest	NULL
in	NULL
that	NULL
its	NULL
expression	NULL
is	NULL
largely	NULL
restricted	NULL
to	NULL
T	NULL
lymphocytes	NULL
and	NULL
neurons	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

CaMKIV/Gr	NULL
is	NULL
the	NULL
product	NULL
of	NULL
a	NULL
single	NULL
gene	NULL
and	NULL
is	NULL
expressed	NULL
in	NULL
tissues	NULL
as	NULL
two	NULL
monomeric	NULL
isoforms	NULL
,	NULL
both	NULL
of	NULL
which	NULL
share	NULL
a	NULL
domain	NULL
structure	NULL
common	NULL
to	NULL
other	NULL
CaMKs	NULL
and	NULL
that	NULL
includes	NULL
a	NULL
catalytic	NULL
domain	NULL
,	NULL
a	NULL
calmodulin-binding	NULL
domain	NULL
,	NULL
and	NULL
an	NULL
associative	NULL
domain	NULL
(	NULL
7-10	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
documented	NULL
the	NULL
presence	NULL
of	NULL
CaMKIV/Gr	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
,	NULL
and	NULL
the	NULL
kinase	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
phosphorylate	NULL
and	NULL
transactivate	NULL
the	NULL
transcription	NULL
factor	NULL
cAMP	NULL
response	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
12-15	NULL
)	NULL
,	NULL
establishing	NULL
a	NULL
role	NULL
for	NULL
CaMKIV/Gr	NULL
as	NULL
a	NULL
Ca**-dependent	NULL
transcriptional	NULL
regulator	NULL
.	NULL

In	NULL
T	NULL
lymphocytes	NULL
,	NULL
CaMKIV/Gr	NULL
is	NULL
selectively	NULL
enriched	NULL
in	NULL
the	NULL
CD4*	NULL
subpopulation	NULL
.	NULL

When	NULL
isolated	NULL
from	NULL
resting	NULL
T	NULL
cells	NULL
it	NULL
exhibits	NULL
minimal	NULL
catalytic	NULL
activity	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Ca**	NULL
and	NULL
calmodulin	NULL
.	NULL

Its	NULL
activity	NULL
is	NULL
strongly	NULL
upregulated	NULL
upon	NULL
antigen	NULL
receptor	NULL
stimulation	NULL
(	NULL
6	NULL
,	NULL
16	NULL
,	NULL
17	NULL
)	NULL
by	NULL
a	NULL
mechanism	NULL
involving	NULL
a	NULL
protein	NULL
kinase	NULL
cascade	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

This	NULL
indicated	NULL
that	NULL
CaMKIV/Gr	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
Ca**-dependent	NULL
transcriptional	NULL
events	NULL
triggered	NULL
by	NULL
antigen	NULL
receptor	NULL
signaling	NULL
that	NULL
are	NULL
critical	NULL
to	NULL
the	NULL
helper	NULL
functions	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
namely	NULL
the	NULL
production	NULL
of	NULL
lymphokines	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
capacity	NULL
of	NULL
CaMKIV/Gr	NULL
to	NULL
activate	NULL
lymphokine	NULL
gene	NULL
transcription	NULL
using	NULL
the	NULL
IL-2	NULL
promoter	NULL
as	NULL
a	NULL
model	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
CaMKIV/Gr	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
promoting	NULL
IL-2	NULL
gene	NULL
transcription	NULL
,	NULL
in	NULL
part	NULL
101	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/96/07/101/12	NULL
$	NULL
2.00	NULL
Volume	NULL
184	NULL
July	NULL
1996	NULL
101-112	NULL
by	NULL
mediating	NULL
a	NULL
novel	NULL
,	NULL
Ca**-dependent	NULL
pathway	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
activation	NULL
protein	NULL
1	NULL
(	NULL
AP-1	NULL
)	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cells	NULL
.	NULL

Jurkat	NULL
Tag	NULL
cells	NULL
are	NULL
derived	NULL
from	NULL
the	NULL
Jurkat	NULL
human	NULL
leukemia	NULL
T	NULL
cell	NULL
line	NULL
and	NULL
stably	NULL
express	NULL
the	NULL
SV40	NULL
large	NULL
T	NULL
antigen	NULL
(	NULL
2	NULL
)	NULL
.	NULL

They	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

BJAB	NULL
,	NULL
an	NULL
EBV-negative	NULL
Burkitt	NULL
lymphoma	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
HeLa	NULL
,	NULL
a	NULL
cervical	NULL
adenocarcinoma	NULL
cell	NULL
line	NULL
,	NULL
were	NULL
maintained	NULL
in	NULL
DMEM	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Plasmids	NULL
.	NULL

-	NULL
FLAG	NULL
epitope-tagged	NULL
wild-type	NULL
human	NULL
CaMKIV/	NULL
Gr	NULL
(	NULL
CaMKIV/Gr	NULL
{	NULL
wt	NULL
}	NULL
)	NULL
was	NULL
derived	NULL
and	NULL
subcloned	NULL
into	NULL
pSGS5	NULL
vector	NULL
as	NULL
described	NULL
(	NULL
11	NULL
)	NULL
.	NULL

CaMKIV/Gr	NULL
{	NULL
(	NULL
wt	NULL
)	NULL
contains	NULL
an	NULL
eight-amino	NULL
acid	NULL
FLAG	NULL
epitope	NULL
at	NULL
its	NULL
NH	NULL
,	NULL
terminus	NULL
to	NULL
allow	NULL
detection	NULL
by	NULL
immunoblotting	NULL
.	NULL

Inactive	NULL
CaMKIV/Gr	NULL
(	NULL
CaMKIV/Gr	NULL
[	NULL
i	NULL
]	NULL
)	NULL
was	NULL
prepared	NULL
by	NULL
substituting	NULL
the	NULL
conserved	NULL
Lys75	NULL
in	NULL
the	NULL
ATP-binding	NULL
site	NULL
of	NULL
CaMKIV/Gr	NULL
{	NULL
wt	NULL
)	NULL
with	NULL
a	NULL
Glu	NULL
residue	NULL
by	NULL
site-directed	NULL
mu-tagenesis	NULL
using	NULL
the	NULL
unique	NULL
site	NULL
elimination	NULL
method	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
constitutively	NULL
active	NULL
CaMKIV/Gr	NULL
mutant	NULL
ACaMKIV/Gr	NULL
{	NULL
(	NULL
c	NULL
)	NULL
was	NULL
prepared	NULL
by	NULL
replacing	NULL
the	NULL
Gin318	NULL
codon	NULL
of	NULL
CaMKIV/Gr	NULL
{	NULL
wt	NULL
)	NULL
with	NULL
a	NULL
stop	NULL
codon	NULL
.	NULL

ACaMKIV/Gr	NULL
{	NULL
(	NULL
c	NULL
)	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
and	NULL
is	NULL
not	NULL
activated	NULL
by	NULL
Ca**/calmodulin	NULL
.	NULL

The	NULL
double	NULL
mutant	NULL
constitutive/inactive	NULL
ACaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
was	NULL
prepared	NULL
by	NULL
mutating	NULL
Lys75	NULL
of	NULL
ACaMKIV/	NULL
Gr	NULL
(	NULL
c	NULL
)	NULL
into	NULL
a	NULL
Glu	NULL
.	NULL

cDNA	NULL
of	NULL
all	NULL
CaMKIV/Gr	NULL
mutants	NULL
were	NULL
sequenced	NULL
and	NULL
ascertained	NULL
to	NULL
be	NULL
free	NULL
of	NULL
errors	NULL
.	NULL

The	NULL
constitutively	NULL
active	NULL
human	NULL
CaMKII-ys	NULL
mutant	NULL
(	NULL
CaMKII	NULL
[	NULL
c	NULL
]	NULL
)	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr.	NULL
Howard	NULL
Schulman	NULL
(	NULL
Stanford	NULL
University	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
was	NULL
generated	NULL
by	NULL
substituting	NULL
Thr287	NULL
in	NULL
the	NULL
autoinhibitory	NULL
domain	NULL
with	NULL
an	NULL
Asp	NULL
residue	NULL
(	NULL
20	NULL
)	NULL
.	NULL

CaMKII	NULL
(	NULL
c	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pSG5	NULL
for	NULL
use	NULL
in	NULL
our	NULL
studies	NULL
.	NULL

The	NULL
plasmid	NULL
IL-2	NULL
luciferase	NULL
contains	NULL
bp	NULL
-326	NULL
to	NULL
+45	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
enhancer/promoter	NULL
directing	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
luciferase	NULL
contains	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
NFAT	NULL
site	NULL
in	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
(	NULL
21	NULL
)	NULL
,	NULL
and	NULL
AP-1	NULL
luciferase	NULL
contains	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
in	NULL
the	NULL
rodent	NULL
a	NULL
chorionic	NULL
gonadotropin	NULL
gene	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
CMV	NULL
-luciferase	NULL
contains	NULL
a	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
immediate	NULL
early	NULL
promoter	NULL
region	NULL
of	NULL
CMV	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
c-fos-chloramphenicol	NULL
acetyl	NULL
transferase	NULL
(	NULL
CAT	NULL
)	NULL
contains	NULL
bp	NULL
-356	NULL
to	NULL
+109	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
coupled	NULL
to	NULL
a	NULL
CAT	NULL
gene	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
plasmids	NULL
pEF-v-Ha-ras	NULL
and	NULL
pEF-Ha-ras-N17	NULL
ras	NULL
encode	NULL
a	NULL
constitutively	NULL
active	NULL
and	NULL
a	NULL
catalytically	NULL
inactive	NULL
mutant	NULL
of	NULL
p21Ha-ras	NULL
,	NULL
respectively	NULL
(	NULL
25	NULL
)	NULL
.	NULL

cDNA	NULL
encoding	NULL
the	NULL
cytoplasmic	NULL
component	NULL
of	NULL
NFAT	NULL
(	NULL
NFATc	NULL
)	NULL
was	NULL
fitted	NULL
with	NULL
EcoRI	NULL
linkers	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
the	NULL
vector	NULL
pBJ5	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
Vitro	NULL
Transcription	NULL
/	NULL
Translation	NULL
Studies	NULL
.	NULL

-	NULL
In	NULL
these	NULL
studies	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
cDNA	NULL
encoding	NULL
either	NULL
wild-type	NULL
or	NULL
mutant	NULL
CaMKIV/Gr	NULL
proteins	NULL
were	NULL
transcribed	NULL
and	NULL
translated	NULL
in	NULL
vitro	NULL
using	NULL
the	NULL
TNT	NULL
transcription	NULL
and	NULL
translation	NULL
system	NULL
(	NULL
Promega	NULL
Corp.	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
.	NULL

When	NULL
indi-cated	NULL
,	NULL
the	NULL
proteins	NULL
were	NULL
metabolically	NULL
labeled	NULL
during	NULL
the	NULL
translation	NULL
process	NULL
by	NULL
including	NULL
4	NULL
wCi	NULL
of	NULL
[	NULL
*S	NULL
)	NULL
methionine	NULL
in	NULL
the	NULL
transcription/translation	NULL
reaction	NULL
mixture	NULL
.	NULL

The	NULL
labeled	NULL
products	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
10	NULL
%	NULL
denaturing	NULL
acrylamide	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Assay	NULL
of	NULL
Recombinant	NULL
Kinase	NULL
Activity	NULL
.	NULL

-	NULL
Recombinant	NULL
CaMKIV/	NULL
Gr	NULL
and	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
proteins	NULL
were	NULL
expressed	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
translation	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Kinase	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
for	NULL
10	NULL
min	NULL
at	NULL
23°C	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
50	NULL
pl	NULL
containing	NULL
25	NULL
pl	NULL
of	NULL
the	NULL
transcription/translation	NULL
reaction	NULL
and	NULL
25	NULL
pl	NULL
of	NULL
a	NULL
kinase	NULL
reaction	NULL
mixture	NULL
consisting	NULL
of	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mM	NULL
MgC	NULL
)	NULL
,	NULL
50	NULL
uM	NULL
ATP	NULL
,	NULL
4	NULL
mCi	NULL
y-	NULL
[	NULL
PPPJATP	NULL
,	NULL
20	NULL
M	NULL
of	NULL
the	NULL
substrate	NULL
peptide	NULL
syntide-2	NULL
(	NULL
Bachem	NULL
,	NULL
Torrance	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
either	NULL
5	NULL
mM	NULL
CaCl	NULL
,	NULL
and	NULL
600	NULL
nM	NULL
calmodulin	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
or	NULL
5	NULL
mM	NULL
EGTA	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
spotting	NULL
25	NULL
pl	NULL
of	NULL
the	NULL
mixture	NULL
onto	NULL
P81	NULL
phosphocellulose	NULL
filters	NULL
(	NULL
Whatman	NULL
,	NULL
Maid-stone	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
0.5	NULL
%	NULL
phosphoric	NULL
acid	NULL
,	NULL
allowed	NULL
to	NULL
air	NULL
dry	NULL
,	NULL
and	NULL
counted	NULL
.	NULL

Detection	NULL
of	NULL
Recombinant	NULL
Kinase	NULL
Proteins	NULL
in	NULL
Cells	NULL
.	NULL

-	NULL
Expression	NULL
of	NULL
recombinant	NULL
CaMKIV/Gr	NULL
in	NULL
cells	NULL
was	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
using	NULL
an	NULL
anti-FLAG	NULL
epitope	NULL
antibody	NULL
(	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
CaMKIV/Gr	NULL
constructs	NULL
were	NULL
lysed	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
25	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
0.5	NULL
%	NULL
NP40	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
25	NULL
mM	NULL
NaH	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
25	NULL
mM	NULL
NaF	NULL
,	NULL
12.5	NULL
mM	NULL
Na	NULL
,	NULL
P	NULL
;	NULL
,0	NULL
,	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
2	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO4	NULL
,	NULL
100	NULL
mg/ml	NULL
PMSF	NULL
,	NULL
and	NULL
10	NULL
mg/ml	NULL
of	NULL
the	NULL
pro-tease	NULL
inhibitor	NULL
leupeptin	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
cleared	NULL
of	NULL
nuclei	NULL
and	NULL
other	NULL
insoluble	NULL
material	NULL
by	NULL
centrifugation	NULL
at	NULL
16,000	NULL
g	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

100	NULL
ug	NULL
of	NULL
the	NULL
lysate	NULL
proteins	NULL
was	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
then	NULL
electroblotted	NULL
onto	NULL
nitrocellullose	NULL
membranes	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
a	NULL
Tris-buft-ered	NULL
saline	NULL
solution	NULL
(	NULL
TBST	NULL
;	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
detergent	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
;	NULL
they	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
more	NULL
with	NULL
M2	NULL
anti-FLAG	NULL
epitope	NULL
antibody	NULL
at	NULL
1	NULL
pg/ml	NULL
in	NULL
TBST	NULL
solution	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
incubated	NULL
with	NULL
horseradish	NULL
peroxidase	NULL
,	NULL
conjugated	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
}	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
subsequently	NULL
washed	NULL
and	NULL
developed	NULL
using	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
system	NULL
for	NULL
peroxidase-based	NULL
detection	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

Endogenous	NULL
CaMKIV/Gr	NULL
in	NULL
cells	NULL
was	NULL
also	NULL
detected	NULL
by	NULL
immunoblotting	NULL
as	NULL
detailed	NULL
above	NULL
but	NULL
using	NULL
as	NULL
a	NULL
primary	NULL
antibody	NULL
1:1,000	NULL
dilution	NULL
of	NULL
a	NULL
rabbit	NULL
antiserum	NULL
that	NULL
is	NULL
directed	NULL
against	NULL
the	NULL
terminal	NULL
17	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
human	NULL
enzyme	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
recombinant	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
was	NULL
visualized	NULL
by	NULL
calmodulin	NULL
overlay	NULL
blotting	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
incubated	NULL
with	NULL
biotinylated	NULL
calmodulin	NULL
at	NULL
1	NULL
pg/ml	NULL
in	NULL
TBST	NULL
solution	NULL
containing	NULL
CaCl	NULL
;	NULL
at	NULL
0.5	NULL
mM	NULL
and	NULL
MgC	NULL
]	NULL
;	NULL
at	NULL
50	NULL
mM	NULL
,	NULL
and	NULL
the	NULL
two	NULL
salts	NULL
were	NULL
also	NULL
included	NULL
in	NULL
the	NULL
entire	NULL
immunoblotting	NULL
process	NULL
.	NULL

After	NULL
wash-ing	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
incubated	NULL
with	NULL
horseradish	NULL
peroxidase-conju-gated	NULL
streptavidin	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
,	NULL
then	NULL
washed	NULL
again	NULL
and	NULL
developed	NULL
using	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
system	NULL
.	NULL

Transfections	NULL
and	NULL
Reporter	NULL
Assays	NULL
.	NULL

Jurkat	NULL
Tag	NULL
cells	NULL
were	NULL
suspended	NULL
at	NULL
1.5	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
RPMI	NULL
medium	NULL
,	NULL
mixed	NULL
with	NULL
the	NULL
indicated	NULL
plasmids	NULL
,	NULL
then	NULL
transfected	NULL
by	NULL
electroporation	NULL
at	NULL
250	NULL
V	NULL
and	NULL
960	NULL
F.	NULL
BJAB	NULL
cells	NULL
were	NULL
suspended	NULL
at	NULL
10	NULL
``	NULL
cells	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
DMEM	NULL
medium	NULL
and	NULL
transfected	NULL
by	NULL
electroporation	NULL
at	NULL
220	NULL
V	NULL
and	NULL
960	NULL
pF	NULL
.	NULL

Hela	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
handled	NULL
as	NULL
detailed	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Luciferase	NULL
and	NULL
CAT	NULL
activities	NULL
were	NULL
assayed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Results	NULL
were	NULL
normalized	NULL
for	NULL
protein	NULL
content	NULL
and	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
over	NULL
values	NULL
obtained	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
reporter	NULL
gene	NULL
and	NULL
empty	NULL
vectors	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays	NULL
.	NULL

-	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
conducted	NULL
as	NULL
previously	NULL
described	NULL
,	NULL
with	NULL
modifications	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

For	NULL
PMA	NULL
induction	NULL
of	NULL
AP-1	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
25	NULL
ng/ml	NULL
of	NULL
PMA	NULL
for	NULL
1	NULL
h	NULL
before	NULL
harvesting	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
dithicerythritol	NULL
,	NULL
0.2	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
pg/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
0.025	NULL
%	NULL
NP40	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
pelleted	NULL
and	NULL
then	NULL
extracted	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
420	NULL
mM	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
dithicerythritol	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.2	NULL
mM	NULL
102	NULL
Ca*+	NULL
Signaling	NULL
Pathways	NULL
in	NULL
T	NULL
Lymphocytes	NULL
PMSF	NULL
,	NULL
10	NULL
pg/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
.	NULL

For	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
5	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
was	NULL
incubated	NULL
together	NULL
with	NULL
0.1	NULL
ng	NULL
of	NULL
P-labeled	NULL
double	NULL
stranded	NULL
monomers	NULL
of	NULL
the	NULL
indicated	NULL
response	NULL
elements	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
dithicerythritol	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
0.5-1	NULL
pg/ml	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

Gel	NULL
shift	NULL
probes	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
included	NULL
:	NULL
the	NULL
AP-1-binding	NULL
site	NULL
found	NULL
in	NULL
the	NULL
human	NULL
metalothionein	NULL
promoter	NULL
,	NULL
GACTCAGCGCGG-3	NULL
'	NULL
(	NULL
31	NULL
)	NULL
;	NULL
a	NULL
mutant	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
the	NULL
aforementioned	NULL
AP-1	NULL
site	NULL
(	NULL
mAP-1	NULL
)	NULL
that	NULL
displays	NULL
poor	NULL
affinity	NULL
for	NULL
AP-1	NULL
,	NULL
5	NULL
!	NULL

-GATCCAAGACTCTGCGCGG-3	NULL
'	NULL
(	NULL
32	NULL
)	NULL
;	NULL
and	NULL
the	NULL
murine	NULL
IL-2	NULL
distal	NULL
NFAT	NULL
-binding	NULL
site	NULL
,	NULL
5	NULL
!	NULL

-GATCGC-CCAAAGAGGAAAATTTGTTTCATACAG-3	NULL
'	NULL
(	NULL
33	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
was	NULL
included	NULL
in	NULL
the	NULL
reaction	NULL
mixture	NULL
.	NULL

After	NULL
30	NULL
min	NULL
of	NULL
incubation	NULL
at	NULL
23°C	NULL
,	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
resolved	NULL
on	NULL
a	NULL
pre-run	NULL
5	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Results	NULL
Characterization	NULL
of	NULL
CaMKIV/Gr	NULL
Constructs	NULL
.	NULL

-	NULL
To	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
CaMKIV/Gr	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
,	NULL
we	NULL
generated	NULL
cDNA	NULL
constructs	NULL
encoding	NULL
recombinant	NULL
wild-type	NULL
and	NULL
mutant	NULL
CaMKIV/Gr	NULL
proteins	NULL
and	NULL
examined	NULL
the	NULL
capacity	NULL
of	NULL
these	NULL
proteins	NULL
to	NULL
recapitulate	NULL
some	NULL
of	NULL
the	NULL
activation	NULL
events	NULL
associated	NULL
with	NULL
signaling	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Proteins	NULL
encoded	NULL
A	NULL
B	NULL
m	NULL
m	NULL
4	NULL
U	NULL
el	NULL
3	NULL
C	NULL
¥	NULL
x	NULL
T	NULL
(	NULL
5	NULL
[	NULL
G	NULL
]	NULL
Q	NULL
5	NULL
_	NULL
m	NULL
~	NULL
~	NULL
>	NULL
~	NULL
>	NULL
o	NULL
5°	NULL
2	NULL
2	NULL
¥	NULL
y	NULL
=	NULL
CG	NULL
&	NULL
o	NULL
%	NULL
©	NULL
o	NULL
-	NULL
G	NULL
®	NULL
>	NULL
Q	NULL
J	NULL
4	NULL
4	NULL
o	NULL
407	NULL
am	NULL
fs	NULL
]	NULL
3	NULL
«	NULL
i	NULL
>	NULL
l	NULL
``	NULL
O	NULL
4	NULL
50	NULL
-	NULL
[	NULL
42	NULL
«	NULL
o	NULL
20	NULL
{	NULL
i_	NULL
6	NULL
a	NULL
.	NULL

5	NULL
38	NULL
-	NULL
o	NULL
9	NULL
10	NULL
Yol	NULL
a.	NULL
rar	NULL
M	NULL
o	NULL
Figure	NULL
1.	NULL
by	NULL
these	NULL
constructs	NULL
include	NULL
CaMKIV/Gr	NULL
{	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
its	NULL
inactive	NULL
counterpart	NULL
CaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
,	NULL
ACaMKIV/Gr	NULL
{	NULL
(	NULL
c	NULL
)	NULL
and	NULL
the	NULL
constitutively	NULL
active	NULL
mutant	NULL
and	NULL
its	NULL
inactive	NULL
counterpart	NULL
ACaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
utilized	NULL
in	NULL
our	NULL
studies	NULL
a	NULL
construct	NULL
generated	NULL
by	NULL
Nghiem	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
,	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
.	NULL

It	NULL
is	NULL
an	NULL
isoform	NULL
of	NULL
CaMKII	NULL
that	NULL
is	NULL
expressed	NULL
in	NULL
several	NULL
tissues	NULL
,	NULL
including	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

CaMKII	NULL
(	NULL
c	NULL
)	NULL
binds	NULL
to	NULL
and	NULL
its	NULL
constitutive	NULL
activity	NULL
is	NULL
upregulated	NULL
by	NULL
Ca**/calmodulin	NULL
,	NULL
and	NULL
it	NULL
was	NULL
used	NULL
in	NULL
our	NULL
studies	NULL
as	NULL
a	NULL
kinase	NULL
specificity	NULL
control	NULL
.	NULL

The	NULL
characteristics	NULL
of	NULL
recombinant	NULL
CaMKIV/Gr	NULL
and	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
proteins	NULL
are	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
A	NULL
shows	NULL
the	NULL
migration	NULL
profile	NULL
on	NULL
SDS/PAGE	NULL
of	NULL
recombinant	NULL
CaMKIV/Gr	NULL
and	NULL
CaMKIl	NULL
(	NULL
c	NULL
)	NULL
proteins	NULL
that	NULL
have	NULL
been	NULL
expressed	NULL
in	NULL
vitro	NULL
and	NULL
labeled	NULL
with	NULL
using	NULL
a	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
transcription	NULL
translation	NULL
system	NULL
.	NULL

CaMKIV/Gr	NULL
{	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
CaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
resolved	NULL
as	NULL
a	NULL
58-kD	NULL
band	NULL
on	NULL
SDS/PAGE	NULL
.	NULL

CaMKII	NULL
(	NULL
c	NULL
)	NULL
resolved	NULL
as	NULL
a	NULL
single	NULL
60-kD	NULL
band	NULL
,	NULL
whereas	NULL
both	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
and	NULL
ACaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
resolved	NULL
as	NULL
a	NULL
40-kD	NULL
band	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
B	NULL
demonstrates	NULL
the	NULL
activity	NULL
profile	NULL
of	NULL
the	NULL
respective	NULL
recombinant	NULL
kinase	NULL
proteins	NULL
.	NULL

Specifically	NULL
,	NULL
CaMKIV/Gr	NULL
{	NULL
wt	NULL
)	NULL
mediated	NULL
Ca**/calmodulin-dependent	NULL
phosphorylation	NULL
of	NULL
substrate	NULL
peptide	NULL
whereas	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
exhibited	NULL
constitutive	NULL
activity	NULL
independent	NULL
of	NULL
Ca**/calmodulin	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
and	NULL
ACaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
were	NULL
both	NULL
inactive	NULL
.	NULL

CaMKII	NULL
(	NULL
c	NULL
)	NULL
exhibited	NULL
constitutive	NULL
activity	NULL
that	NULL
was	NULL
further	NULL
upregulated	NULL
by	NULL
Ca*+*/	NULL
calmodulin	NULL
.	NULL

Q	NULL
EctaA	NULL
W	NULL
Ca2+/Calmodulin	NULL
Vector	NULL
CaMKIV/Gr	NULL
{	NULL
(	NULL
wt	NULL
)	NULL
CaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
ACaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
Characterization	NULL
of	NULL
recombinant	NULL
CaMK	NULL
proteins	NULL
.	NULL

(	NULL
4	NULL
)	NULL
SDS/PAGE	NULL
analysis	NULL
of	NULL
S-labeled	NULL
,	NULL
in	NULL
vitro	NULL
transcribed	NULL
and	NULL
translated	NULL
recombinant	NULL
CaMKIV/Gr	NULL
and	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
proteins	NULL
.	NULL

The	NULL
numbers	NULL
on	NULL
the	NULL
left	NULL
represent	NULL
mol	NULL
wt	NULL
markers	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Phosphorylation	NULL
of	NULL
the	NULL
substrate	NULL
peptide	NULL
syntide-2	NULL
by	NULL
in	NULL
vitro	NULL
transcribed	NULL
and	NULL
translated	NULL
recombinant	NULL
CaMK	NULL
proteins	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
picomoles	NULL
of	NULL
phosphate	NULL
incorporated	NULL
into	NULL
peptide	NULL
substrate	NULL
over	NULL
the	NULL
course	NULL
of	NULL
the	NULL
reaction	NULL
and	NULL
represent	NULL
means	NULL
of	NULL
triplicate	NULL
determinations	NULL
;	NULL
similar	NULL
results	NULL
were	NULL
found	NULL
in	NULL
two	NULL
other	NULL
experiments	NULL
.	NULL

103	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
expression	NULL
of	NULL
CaMK	NULL
constructs	NULL
in	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
by	NULL
immunoblotting	NULL
and/or	NULL
calmodulin	NULL
overlay	NULL
assays	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
A	NULL
demonstrates	NULL
that	NULL
both	NULL
CaMKIV/Gr	NULL
{	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
CaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
were	NULL
expressed	NULL
as	NULL
two	NULL
monomeric	NULL
«	NULL
/B	NULL
bands	NULL
with	NULL
molecular	NULL
masses	NULL
of	NULL
58	NULL
and	NULL
60	NULL
kD	NULL
,	NULL
respectively	NULL
.	NULL

ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
was	NULL
expressed	NULL
as	NULL
two	NULL
bands	NULL
migrating	NULL
with	NULL
molecular	NULL
masses	NULL
of	NULL
40	NULL
and	NULL
42	NULL
kD	NULL
.	NULL

The	NULL
latter	NULL
band	NULL
represents	NULL
an	NULL
autophosphorylated	NULL
form	NULL
of	NULL
the	NULL
40-kD	NULL
species	NULL
(	NULL
Chatila	NULL
,	NULL
T.	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

ACaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
was	NULL
expressed	NULL
at	NULL
lower	NULL
levels	NULL
as	NULL
a	NULL
single	NULL
40-kD	NULL
band	NULL
.	NULL

In	NULL
separate	NULL
studies	NULL
,	NULL
we	NULL
established	NULL
that	NULL
three	NULL
independent	NULL
inactivating	NULL
mutations	NULL
all	NULL
resulted	NULL
in	NULL
decreased	NULL
expression	NULL
of	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
low	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
ACaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
reflects	NULL
a	NULL
requirement	NULL
for	NULL
an	NULL
autophosphorylation	NULL
event	NULL
to	NULL
stabilize	NULL
this	NULL
mutant	NULL
(	NULL
Chatila	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
A.R	NULL
.	NULL

Means	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
determined	NULL
that	NULL
when	NULL
expressed	NULL
at	NULL
levels	NULL
comparable	NULL
with	NULL
those	NULL
of	NULL
ACaMKIV/	NULL
Gr	NULL
(	NULL
i	NULL
)	NULL
,	NULL
the	NULL
constitutively	NULL
active	NULL
kinase	NULL
mutant	NULL
exhibited	NULL
activity	NULL
equivalent	NULL
to	NULL
~15	NULL
%	NULL
of	NULL
that	NULL
found	NULL
with	NULL
unrestricted	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
expression	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
,	NULL
low	NULL
levels	NULL
of	NULL
a	NULL
split	NULL
product	NULL
of	NULL
CaMKIV/Gr	NULL
{	NULL
wt	NULL
)	NULL
could	NULL
be	NULL
detected	NULL
that	NULL
comigrated	NULL
with	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
B	NULL
demonstrates	NULL
that	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
was	NULL
well	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
as	NULL
detected	NULL
by	NULL
calmodulin	NULL
overlay	NULL
assays	NULL
.	NULL

In	NULL
separate	NULL
studies	NULL
,	NULL
it	NULL
could	NULL
be	NULL
demonstrated	NULL
by	NULL
calmodulin	NULL
overlay	NULL
assays	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
CaMKIlI	NULL
(	NULL
c	NULL
)	NULL
achieved	NULL
in	NULL
A	NULL
B	NULL
m	NULL
o	NULL
n	NULL
&	NULL
a	NULL
$	NULL
7	NULL
8	NULL
$	NULL
f	NULL
$	NULL
~	NULL
m	NULL
%	NULL
on	NULL
3	NULL
>	NULL
U	NULL
5	NULL
20	NULL
2	NULL
2	NULL
y	NULL
5	NULL
3	NULL
$	NULL
§	NULL
9	NULL
o	NULL
so	NULL
s	NULL
9	NULL
O	NULL
OE	NULL
“	NULL
;	NULL
>	NULL
u	NULL
o	NULL
4	NULL
4	NULL
>	NULL
O	NULL
*~*	NULL
M	NULL
<	NULL
50	NULL
--	NULL
38	NULL
--	NULL
Figure	NULL
2	NULL
.	NULL

Expression	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
CaMKIV/Gr	NULL
and	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Expression	NULL
of	NULL
CaMKIV/Gr	NULL
derivatives	NULL
.	NULL

100	NULL
pug	NULL
of	NULL
protein	NULL
lysates	NULL
derived	NULL
from	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
CaMKIV/Gr	NULL
construct	NULL
were	NULL
resolved	NULL
by	NULL
SDS/PAGE	NULL
and	NULL
probed	NULL
for	NULL
kinase	NULL
expression	NULL
using	NULL
an	NULL
anti-FLAG	NULL
epitope	NULL
antibody	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Expression	NULL
of	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Lysates	NULL
derived	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
pSGS	NULL
vector	NULL
alone	NULL
or	NULL
with	NULL
CaMKII	NULL
{	NULL
(	NULL
c	NULL
)	NULL
in	NULL
pSGS	NULL
were	NULL
resolved	NULL
by	NULL
SDS/	NULL
PAGE	NULL
and	NULL
probed	NULL
for	NULL
calmodulin-binding	NULL
proteins	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
Arrow	NULL
)	NULL
Position	NULL
of	NULL
the	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
band	NULL
.	NULL

lymphoid	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
closely	NULL
approximated	NULL
those	NULL
of	NULL
recombinant	NULL
CaMKIV/Gr	NULL
{	NULL
(	NULL
wt	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
AP-1-dependent	NULL
Transcription	NULL
by	NULL
CaMKIV/	NULL
Gr	NULL
.	NULL

Ca**	NULL
signaling	NULL
pathways	NULL
have	NULL
previously	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
in	NULL
T	NULL
lymphocytes	NULL
by	NULL
mechanisms	NULL
that	NULL
include	NULL
transcriptional	NULL
activation	NULL
of	NULL
c-fos	NULL
(	NULL
34	NULL
)	NULL
and	NULL
posttranscriptional	NULL
activation	NULL
of	NULL
a	NULL
c-Jun	NULL
kinase	NULL
termed	NULL
JNK	NULL
or	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
capacity	NULL
of	NULL
CaMKIV/Gr	NULL
to	NULL
activate	NULL
AP-1-dependent	NULL
transcription	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
the	NULL
respective	NULL
CaMKIV/Gr	NULL
construct	NULL
together	NULL
with	NULL
an	NULL
AP-1-responsive	NULL
luciferase	NULL
reporter	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
subsequently	NULL
examined	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
A	NULL
demonstrates	NULL
that	NULL
transfection	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
a	NULL
construct	NULL
encoding	NULL
CaMKIV/Gr	NULL
{	NULL
(	NULL
wt	NULL
)	NULL
resulted	NULL
in	NULL
an	NULL
eightfold	NULL
upregulation	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

Furthermore	NULL
,	NULL
transfection	NULL
of	NULL
a	NULL
cDNA	NULL
construct	NULL
encoding	NULL
a	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
the	NULL
kinase	NULL
resulted	NULL
in	NULL
50-fold	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

Significantly	NULL
,	NULL
both	NULL
wild-type	NULL
and	NULL
the	NULL
constitutively	NULL
active	NULL
kinase	NULL
mutant	NULL
acted	NULL
in	NULL
synergy	NULL
with	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
and	NULL
with	NULL
the	NULL
TCR-stimulating	NULL
lectin	NULL
PHA	NULL
to	NULL
upregulate	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
reporter	NULL
gene	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
inactive	NULL
CaMKIV/Gr	NULL
mutants	NULL
derived	NULL
from	NULL
the	NULL
wild-type	NULL
and	NULL
constitutively	NULL
active	NULL
kinase	NULL
species	NULL
failed	NULL
to	NULL
induce	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
AP-1	NULL
reporter	NULL
or	NULL
to	NULL
enhance	NULL
PMA	NULL
or	NULL
PHA-induced	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
multifunctional	NULL
CaMKII	NULL
is	NULL
similar	NULL
to	NULL
CaMKIV/Gr	NULL
in	NULL
that	NULL
both	NULL
are	NULL
homologous	NULL
,	NULL
Ca**+/calmodulin-dependent	NULL
protein	NULL
kinases	NULL
that	NULL
exhibit	NULL
broad	NULL
substrate	NULL
specificity	NULL
and	NULL
that	NULL
phosphorylate	NULL
the	NULL
same	NULL
minimal	NULL
consensus	NULL
substrate	NULL
sequence	NULL
(	NULL
RXXS/T	NULL
)	NULL
(	NULL
4	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
the	NULL
capacity	NULL
of	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
for	NULL
its	NULL
capacity	NULL
to	NULL
induce	NULL
AP-1	NULL
.	NULL

We	NULL
found	NULL
that	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
failed	NULL
to	NULL
induce	NULL
AP-1	NULL
activation	NULL
in	NULL
transfected	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
or	NULL
to	NULL
upregulate	NULL
induction	NULL
by	NULL
phorbol	NULL
esters	NULL
and	NULL
PHA	NULL
of	NULL
AP-1	NULL
reporter	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
.	NULL

Other	NULL
reports	NULL
have	NULL
documented	NULL
moderate	NULL
inhibition	NULL
of	NULL
AP-1	NULL
activation	NULL
by	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
CaMKIV/Gr	NULL
induction	NULL
of	NULL
AP-1	NULL
reporter	NULL
gene	NULL
expression	NULL
was	NULL
also	NULL
ascertained	NULL
by	NULL
the	NULL
failure	NULL
of	NULL
ACaMKIV/	NULL
Gr	NULL
(	NULL
c	NULL
)	NULL
to	NULL
upregulate	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
CMV	NULL
immediate	NULL
early	NULL
gene	NULL
promoter	NULL
or	NULL
to	NULL
enhance	NULL
the	NULL
upregulation	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
activity	NULL
by	NULL
PMA	NULL
and	NULL
PHA	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
C	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
AP-1-dependent	NULL
transcription	NULL
by	NULL
CaMKIV/	NULL
Gr	NULL
was	NULL
associated	NULL
with	NULL
increased	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
performed	NULL
using	NULL
a	NULL
radiolabeled	NULL
AP-1-binding	NULL
oligonucleotide	NULL
probe	NULL
revealed	NULL
enhanced	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
-transfected	NULL
Jurkat	NULL
cells	NULL
as	NULL
compared	NULL
with	NULL
those	NULL
extracts	NULL
isolated	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
vector	NULL
alone	NULL
or	NULL
with	NULL
ACaMKIV/Gr	NULL
(	NULL
i	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
by	NULL
ACaMKIV/Gr	NULL
{	NULL
(	NULL
c	NULL
)	NULL
was	NULL
less	NULL
than	NULL
that	NULL
observed	NULL
upon	NULL
treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
PMA	NULL
.	NULL

This	NULL
can	NULL
be	NULL
explained	NULL
in	NULL
part	NULL
by	NULL
the	NULL
low	NULL
number	NULL
of	NULL
Jurkat	NULL
cells	NULL
successfully	NULL
transfected	NULL
with	NULL
ACaMKIV/	NULL
Gr	NULL
(	NULL
c	NULL
)	NULL
(	NULL
typically	NULL
20-30	NULL
%	NULL
)	NULL
as	NULL
compared	NULL
with	NULL
100	NULL
%	NULL
of	NULL
cells	NULL
being	NULL
amenable	NULL
to	NULL
PMA	NULL
treatment	NULL
.	NULL

104	NULL
Ca++	NULL
Signaling	NULL
Pathways	NULL
in	NULL
T	NULL
Lymphocytes	NULL
>	NULL
60	NULL
50	NULL
40	NULL
30	NULL
20	NULL
|	NULL
\	NULL
AP:1	NULL
Luciferase	NULL
Activity	NULL
(	NULL
Fold	NULL
Induction	NULL
)	NULL
5	NULL
a-	NULL
__	NULL
~	NULL
-~	NULL
8	NULL
B	NULL
<	NULL
S	NULL
=	NULL
S	NULL
£	NULL
<	NULL
$	NULL
5	NULL
$	NULL
5	NULL
z	NULL
S	NULL
=	NULL
s	NULL
=	NULL
3	NULL
=	NULL
re	NULL
o	NULL
w	NULL
Fel	NULL
w	NULL
3	NULL
=	NULL
3	NULL
x	NULL
s	NULL
3	NULL
©	NULL
8	NULL
&	NULL
3	NULL
4	NULL
<	NULL
3	NULL
B	NULL
L_	NULL
1500	NULL
&	NULL
.S	NULL
S	NULL
a	NULL
iS	NULL
=	NULL
1000	NULL
F	NULL
]	NULL
PHA	NULL
cal	NULL
M	NULL
Pva	NULL
F	NULL
Z	NULL
5	NULL
<	NULL
soo	NULL
@	NULL
(	NULL
I	NULL
)	NULL
&	NULL
£	NULL
o	NULL
3	NULL
-	NULL
0	NULL
T	NULL
8	NULL
=	NULL
al	NULL
=	NULL
3	NULL
B	NULL
z	NULL
s	NULL
G	NULL
=	NULL
S	NULL
=	NULL
<	NULL
5	NULL
s	NULL
&	NULL
©	NULL
C	NULL
§	NULL
0	NULL
s	NULL
§	NULL
5	NULL
x	NULL
=	NULL
re	NULL
se	NULL
x	NULL
3	NULL
x	NULL
3	NULL
3	NULL
%	NULL
E3	NULL
=	NULL
3	NULL
o	NULL
Fas	NULL
<	NULL
G	NULL
&	NULL
4	NULL
<	NULL
C	NULL
C	NULL
]	NULL
Medium	NULL
£1	NULL
PHa	NULL
M	NULL
rua	NULL
CMV-Luciferase	NULL
Activity	NULL
(	NULL
Fold	NULL
Induction	NULL
)	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
Activation	NULL
of	NULL
AP-1	NULL
by	NULL
CaMKIV/Gr	NULL
.	NULL

(	NULL
4	NULL
)	NULL
CaMKIV/Gr	NULL
independently	NULL
activates	NULL
AP-1-dependent	NULL
gene	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Jurkat	NULL
Tag	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
5	NULL
pug	NULL
of	NULL
AP-1-luciferase	NULL
reporter	NULL
gene	NULL
together	NULL
with	NULL
30	NULL
jug	NULL
of	NULL
empty	NULL
pSGS5	NULL
vector	NULL
(	NULL
Vector	NULL
)	NULL
or	NULL
pSGS5	NULL
encoding	NULL
wild-type	NULL
CaMKIV/Gr	NULL
(	NULL
CaMKIV/Grfwt	NULL
]	NULL
)	NULL
,	NULL
inactive	NULL
CaMKIV/	NULL
Gr	NULL
(	NULL
CaMKIV/Grfif	NULL
)	NULL
,	NULL
constitutively	NULL
active	NULL
CaMKIV/Gr	NULL
(	NULL
ACaMKIV/	NULL
Grfc	NULL
]	NULL
)	NULL
,	NULL
double	NULL
mutant	NULL
constitutive/inactive	NULL
(	NULL
ACaMKIV/Grfi	NULL
}	NULL
}	NULL
)	NULL
,	NULL
or	NULL
a	NULL
constitutively	NULL
active	NULL
CaMKII-yg	NULL
mutant	NULL
(	NULL
CaMKIIfc	NULL
]	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
,	NULL
then	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

(	NULL
B	NULL
)	NULL
CaMKIV/Gr	NULL
upregulates	NULL
AP-1	NULL
activation	NULL
by	NULL
T	NULL
cell	NULL
mitogens	NULL
.	NULL

Jurkat	NULL
Tag	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
AP-1	NULL
reporter	NULL
gene	NULL
and	NULL
the	NULL
indicated	NULL
constructs	NULL
were	NULL
stimulated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
PHA-P	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
or	NULL
PMA	NULL
(	NULL
25	NULL
ng/	NULL
mi	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
CaMKIV/Gr	NULL
does	NULL
not	NULL
activate	NULL
transcription	NULL
from	NULL
the	NULL
CMV	NULL
immediate	NULL
early	NULL
gene	NULL
promoter	NULL
.	NULL

Jurkat	NULL
Tag	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
0.5	NULL
wg	NULL
of	NULL
CMV-luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
23	NULL
)	NULL
;	NULL
30	NULL
jug	NULL
of	NULL
the	NULL
indicated	NULL
constructs	NULL
were	NULL
then	NULL
stimulated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
PHA-P	NULL
or	NULL
with	NULL
PMA	NULL
.	NULL

Data	NULL
in	NULL
A	NULL
and	NULL
B	NULL
represent	NULL
means	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
to	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

Data	NULL
in	NULL
C	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

105	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
p21	NULL
``	NULL
®-regulated	NULL
signaling	NULL
pathway	NULL
(	NULL
s	NULL
)	NULL
are	NULL
involved	NULL
in	NULL
TCR	NULL
coupling	NULL
to	NULL
AP-1	NULL
activation	NULL
(	NULL
39	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
p21'®	NULL
in	NULL
CaMKIV/Gr-dependent	NULL
induction	NULL
of	NULL
AP-1	NULL
,	NULL
we	NULL
monitored	NULL
AP-1	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
cotransfected	NULL
with	NULL
CaMKIV/	NULL
Gr	NULL
and	NULL
either	NULL
a	NULL
mutationally	NULL
activated	NULL
or	NULL
a	NULL
dominant	NULL
negative	NULL
p21	NULL
``	NULL
®	NULL
mutant	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
A	NULL
demonstrates	NULL
that	NULL
CaMKIV/Gr	NULL
acted	NULL
in	NULL
synergy	NULL
with	NULL
activated	NULL
p21	NULL
'	NULL
``	NULL
®	NULL
,	NULL
encoded	NULL
by	NULL
v-Ha-ras	NULL
,	NULL
in	NULL
inducing	NULL
AP-1-dependent	NULL
transcription	NULL
.	NULL

This	NULL
result	NULL
agrees	NULL
with	NULL
the	NULL
data	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
since	NULL
both	NULL
PHA	NULL
and	NULL
PMA	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
convert	NULL
p21	NULL
``	NULL
to	NULL
its	NULL
active	NULL
,	NULL
GTP-bound	NULL
state	NULL
and	NULL
thereby	NULL
activate	NULL
p21'®*-coupled	NULL
pathways	NULL
.	NULL

However	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
demonstrates	NULL
that	NULL
CaMKIV/Gr	NULL
induced	NULL
AP-1	NULL
activation	NULL
by	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
that	NULL
were	NULL
largely	NULL
independent	NULL
of	NULL
p21	NULL
``	NULL
since	NULL
cotransfection	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
p21	NULL
``	NULL
mutant	NULL
Ha-ras-N17	NULL
resulted	NULL
in	NULL
only	NULL
modest	NULL
inhibition	NULL
(	NULL
<	NULL
20	NULL
%	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
and	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
,	NULL
the	NULL
Ha-ras-N17	NULL
mutant	NULL
inhibited	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
activity	NULL
by	NULL
PMA	NULL
by	NULL
~85	NULL
%	NULL
.	NULL

A	NULL
possible	NULL
mechanism	NULL
by	NULL
which	NULL
Ca**	NULL
signaling	NULL
pathways	NULL
may	NULL
activate	NULL
AP-1	NULL
is	NULL
through	NULL
induction	NULL
of	NULL
c-fos	NULL
transcription	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
CaMKIV/Gr	NULL
to	NULL
activate	NULL
c-fos	NULL
transcription	NULL
was	NULL
examined	NULL
by	NULL
cotransfecting	NULL
kinase	NULL
derivatives	NULL
and	NULL
a	NULL
reporter	NULL
gene	NULL
regulated	NULL
by	NULL
the	NULL
c-fos	NULL
enhancer/	NULL
g.	NULL
€	NULL
.	NULL

8	NULL
a.	NULL
to	NULL
-	NULL
o	NULL
Go	NULL
~~	NULL
To	NULL
_	NULL
+	NULL
Lo	NULL
A	NULL
C	NULL
<	NULL
9	NULL
9	NULL
0	NULL
z	NULL
§	NULL
2	NULL
0	NULL
2	NULL
3	NULL
o£	NULL
%	NULL
ExxgsaL	NULL
8	NULL
po	NULL
Z	NULL
2	NULL
3	NULL
B	NULL
2	NULL
€	NULL
Q	NULL
®	NULL
®	NULL
®	NULL
o	NULL
b	NULL
292	NULL
#	NULL
o	NULL
o	NULL
J	NULL
®	NULL
o	NULL
a	NULL
>	NULL
d	NULL
4d	NULL
4	NULL
>	NULL
>	NULL
Od	NULL
<	NULL
==	NULL
#	NULL
pt	NULL
Figure	NULL
4	NULL
.	NULL

Upregulation	NULL
of	NULL
nuclear	NULL
AP-1	NULL
DNA-binding	NULL
activity	NULL
by	NULL
CaMKIV/Gr	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
Tag	NULL
cells	NULL
that	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
either	NULL
pSGS5	NULL
vector	NULL
(	NULL
Vector	NULL
)	NULL
or	NULL
with	NULL
the	NULL
indicated	NULL
kinase	NULL
cDNA	NULL
.	NULL

5	NULL
pug	NULL
of	NULL
the	NULL
respective	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
P-labeled	NULL
AP-1	NULL
oligonucleotide	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
excess	NULL
unlabeled	NULL
competitor	NULL
AP-1	NULL
oligonucleotide	NULL
(	NULL
Comp	NULL
.	NULL
)	NULL

,	NULL
and	NULL
the	NULL
bound	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
5	NULL
%	NULL
nondenaturing	NULL
acrylamide	NULL
gel	NULL
.	NULL

(	NULL
Vector	NULL
+	NULL
PMA	NULL
)	NULL
Nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
Jurkat	NULL
Tag	NULL
cells	NULL
that	NULL
were	NULL
transfected	NULL
with	NULL
pSG5	NULL
vector	NULL
and	NULL
that	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
at	NULL
25	NULL
ng/ml	NULL
for	NULL
1	NULL
h	NULL
before	NULL
cell	NULL
lysis	NULL
.	NULL

(	NULL
Probe	NULL
lane	NULL
)	NULL
Radiolabeled	NULL
reaction	NULL
mixture	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

(	NULL
Arrow	NULL
)	NULL
Specific	NULL
AP-1/DNA	NULL
complexes	NULL
.	NULL

The	NULL
lower	NULL
band	NULL
represents	NULL
a	NULL
nonspecific	NULL
DNA-protein	NULL
complex	NULL
,	NULL
while	NULL
unbound	NULL
radiolabeled	NULL
probe	NULL
was	NULL
allowed	NULL
to	NULL
run	NULL
out	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

200	NULL
é	NULL
E	NULL
80	NULL
S	NULL
S	NULL
g	NULL
€	NULL
60	NULL
3	NULL
s	NULL
£	NULL
2	NULL
€	NULL
=s	NULL
e	NULL
O	NULL
rer	NULL
€	NULL
40	NULL
O	NULL
per	NULL
<	NULL
B	NULL
pEF-vHa-ras	NULL
3	NULL
BH	NULL
pEF-Ha-ras-N17	NULL
&	NULL
a	NULL
Fol	NULL
Po	NULL
§	NULL
§	NULL
»	NULL
&	NULL
te	NULL
§	NULL
3	NULL
‘	NULL
—_l	NULL
a.	NULL
o	NULL
4	NULL
rozen	NULL
7	NULL
o	NULL
I	NULL
s	NULL
Te	NULL
a	NULL
§	NULL
5	NULL
S	NULL
§	NULL
3	NULL
G	NULL
=	NULL
S	NULL
fel	NULL
s	NULL
]	NULL
>	NULL
&	NULL
5	NULL
S	NULL
=	NULL
=	NULL
5	NULL
B	NULL
=	NULL
x	NULL
§	NULL
$	NULL
x	NULL
x	NULL
5	NULL
0	NULL
3	NULL
5	NULL
a	NULL
4a	NULL
3	NULL
a	NULL
C	NULL
D	NULL
6	NULL
80	NULL
AP-1	NULL
C3	NULL
r=	NULL
&	NULL
o	NULL
.S	NULL
8	NULL
§	NULL
cC	NULL
S	NULL
€	NULL
E8	NULL
-	NULL
so	NULL
3	NULL
4	NULL
E	NULL
£	NULL
£	NULL
peat	NULL
E	NULL
#	NULL
|	NULL
§	NULL
40	NULL
C	NULL
]	NULL
Vehicle	NULL
3	NULL
H	NULL
Cyclosporine	NULL
<	NULL
2	NULL
a	NULL
-	NULL
a	NULL
ho	NULL
g.	NULL
A	NULL
E	NULL
20	NULL
G	NULL
C5	NULL
§	NULL
0	NULL
1	NULL
5	NULL
s	NULL
8	NULL
=	NULL
Vector	NULL
CaM	NULL
l	NULL
(	NULL
c	NULL
)	NULL
CaMK	NULL
IVIG	NULL
{	NULL
i	NULL
)	NULL
ACaMK	NULL
:	NULL
IV/Gr	NULL
(	NULL
c	NULL
)	NULL
ACaMK	NULL
:	NULL
Vector	NULL
:	NULL
PHA	NULL
ACaMK	NULL
IV/Gr	NULL
(	NULL
c	NULL
)	NULL
ACaMK	NULL
:	NULL
CaMK	NULL
:	NULL
IVGr	NULL
{	NULL
wi	NULL
)	NULL
Figure	NULL
5	NULL
.	NULL

Characterization	NULL
of	NULL
AP-1	NULL
activation	NULL
by	NULL
CaMKIV/Gr	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Synergistic	NULL
activation	NULL
of	NULL
AP-1	NULL
by	NULL
CaMKIV/Gr	NULL
and	NULL
p21	NULL
``	NULL
***	NULL
``	NULL
.	NULL

Jurkat	NULL
Tag	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
5	NULL
jug	NULL
of	NULL
the	NULL
AP-1	NULL
reporter	NULL
gene	NULL
and	NULL
30	NULL
jug	NULL
of	NULL
the	NULL
respective	NULL
kinase	NULL
construct	NULL
together	NULL
with	NULL
30	NULL
ug	NULL
of	NULL
empty	NULL
pEF	NULL
vector	NULL
or	NULL
pEF	NULL
containing	NULL
the	NULL
constitutively	NULL
active	NULL
p21	NULL
``	NULL
mutant	NULL
v-Ha-ras	NULL
(	NULL
pEF-vHa-ras	NULL
)	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
added	NULL
stimulus	NULL
;	NULL
they	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
over	NULL
levels	NULL
achieved	NULL
upon	NULL
cotransfection	NULL
of	NULL
AP-1	NULL
reporter	NULL
gene	NULL
together	NULL
with	NULL
empty	NULL
pSGS5	NULL
and	NULL
pEF	NULL
vectors	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Resistance	NULL
of	NULL
AP-1	NULL
activation	NULL
by	NULL
CaMKIV/Gr	NULL
to	NULL
inhibition	NULL
by	NULL
Ha-ras-N17	NULL
.	NULL

Jurkat	NULL
Tag	NULL
cells	NULL
were	NULL
cotransfected	NULL
as	NULL
per	NULL
A	NULL
with	NULL
AP-1	NULL
reporter	NULL
and	NULL
the	NULL
indicated	NULL
kinase	NULL
constructs	NULL
together	NULL
with	NULL
empty	NULL
pEF	NULL
vector	NULL
or	NULL
pEF	NULL
containing	NULL
the	NULL
dominant	NULL
negative	NULL
p21	NULL
``	NULL
mutant	NULL
Ha-ras	NULL
N17	NULL
(	NULL
pEF-Ha-res-N17	NULL
)	NULL
.	NULL

PMA	NULL
induction	NULL
of	NULL
AP-1	NULL
was	NULL
performed	NULL
by	NULL
treatment	NULL
with	NULL
25	NULL
ng/ml	NULL
of	NULL
PMA	NULL
during	NULL
the	NULL
last	NULL
6	NULL
h	NULL
of	NULL
the	NULL
incubation	NULL
period	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Transcriptional	NULL
activation	NULL
of	NULL
c-fos	NULL
enhancer/promoter	NULL
by	NULL
CaMKIV/Gr	NULL
.	NULL

Jurkat	NULL
Tag	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
5	NULL
jg	NULL
of	NULL
c-fos	NULL
(	NULL
-356	NULL
to	NULL
+109	NULL
)	NULL
-CAT	NULL
reporter	NULL
gene	NULL
(	NULL
24	NULL
)	NULL
,	NULL
and	NULL
30	NULL
jug	NULL
of	NULL
the	NULL
indicated	NULL
kinase	NULL
construct	NULL
was	NULL
then	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

{	NULL
D	NULL
)	NULL
Resistance	NULL
of	NULL
AP-1	NULL
activation	NULL
by	NULL
CaMK	NULL
IV/Gr	NULL
to	NULL
inhibition	NULL
by	NULL
cyclosporin	NULL
A.	NULL
Jurkat	NULL
Tag	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
either	NULL
the	NULL
AP-1	NULL
or	NULL
NFAT	NULL
reporter	NULL
gene	NULL
(	NULL
21	NULL
)	NULL
together	NULL
with	NULL
the	NULL
indicated	NULL
kinase	NULL
construct	NULL
and	NULL
were	NULL
thereafter	NULL
treated	NULL
for	NULL
48	NULL
h	NULL
in	NULL
culture	NULL
with	NULL
cyclosporin	NULL
A	NULL
at	NULL
100	NULL
ng/ml	NULL
or	NULL
with	NULL
solvent	NULL
alone	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
NFAT	NULL
luciferase	NULL
reporter	NULL
gene	NULL
were	NULL
treated	NULL
with	NULL
PHA-P	NULL
at	NULL
10	NULL
pg/ml	NULL
during	NULL
the	NULL
last	NULL
6	NULL
h	NULL
of	NULL
the	NULL
incubation	NULL
period	NULL
to	NULL
induce	NULL
reporter	NULL
expression	NULL
.	NULL

Data	NULL
presented	NULL
in	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
D	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
for	NULL
each	NULL
panel	NULL
,	NULL
and	NULL
data	NULL
in	NULL
C	NULL
are	NULL
means	NULL
values	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

promoter	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
C	NULL
demonstrates	NULL
that	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
is	NULL
a	NULL
__	NULL
driven	NULL
reporter	NULL
gene	NULL
.	NULL

This	NULL
result	NULL
agrees	NULL
with	NULL
our	NULL
observa-potent	NULL
inducer	NULL
of	NULL
c-fos	NULL
reporter	NULL
gene	NULL
transcription	NULL
in	NULL
Jurkat	NULL
_	NULL
tion	NULL
that	NULL
TCR-dependent	NULL
activation	NULL
of	NULL
CaMKIV/Gr	NULL
is	NULL
cy-cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
CaMKII	NULL
(	NULL
c	NULL
}	NULL
inhibited	NULL
(	NULL
>	NULL
90	NULL
%	NULL
)	NULL
basal	NULL
tran-	NULL
__	NULL
closporin	NULL
A	NULL
resistant	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

scription	NULL
of	NULL
the	NULL
c-fos	NULL
reporter	NULL
.	NULL

Activation	NULL
of	NULL
NFAT	NULL
-dependent	NULL
Transcription	NULL
in	NULL
T	NULL
Cells	NULL
by	NULL
Ca	NULL
``	NULL
*	NULL
may	NULL
also	NULL
act	NULL
in	NULL
synergy	NULL
with	NULL
phorbol	NULL
esters	NULL
to	NULL
acti-	NULL
CaMKIV/Gr	NULL
.	NULL

-	NULL
The	NULL
transcriptional	NULL
complexes	NULL
NFAT	NULL
and	NULL
vate	NULL
AP-1	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
a	NULL
calcineurin-dependent	NULL
mecha-	NULL
_	NULL
NFIL2-A	NULL
regulate	NULL
lymphokine	NULL
gene	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
nism	NULL
that	NULL
involves	NULL
JNK/SAPK	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
mitogen-	NULL
__	NULL
and	NULL
contain	NULL
AP-1	NULL
components	NULL
that	NULL
are	NULL
essential	NULL
for	NULL
the	NULL
func-activated	NULL
protein	NULL
kinase	NULL
family	NULL
that	NULL
phosphorylates	NULL
c-Jun	NULL
and	NULL
__	NULL
tion	NULL
of	NULL
these	NULL
complexes	NULL
(	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
NFAT	NULL
,	NULL
upregulates	NULL
its	NULL
transcriptional	NULL
activity	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

If	NULL
calcineurin	NULL
__	NULL
NFATc	NULL
(	NULL
26	NULL
)	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
to	NULL
combine	NULL
with	NULL
were	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
CaMKIV/Gr-dependent	NULL
activa-	NULL
an	NULL
AP-1	NULL
(	NULL
nuclear	NULL
)	NULL
component	NULL
(	NULL
21	NULL
,	NULL
33	NULL
,	NULL
42	NULL
)	NULL
and	NULL
activates	NULL
tion	NULL
,	NULL
then	NULL
it	NULL
follows	NULL
that	NULL
the	NULL
response	NULL
would	NULL
be	NULL
sensitive	NULL
to	NULL
__	NULL
transcription	NULL
from	NULL
specific	NULL
response	NULL
elements	NULL
.	NULL

Assembly	NULL
and	NULL
the	NULL
immunosuppressive	NULL
drug	NULL
cyclosporin	NULL
A	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
D	NULL
dem-	NULL
__	NULL
activation	NULL
of	NULL
NFAT	NULL
'	NULL
c	NULL
in	NULL
the	NULL
nucleus	NULL
is	NULL
thought	NULL
to	NULL
reflect	NULL
onstrates	NULL
that	NULL
this	NULL
was	NULL
not	NULL
the	NULL
case	NULL
,	NULL
since	NULL
AP-1	NULL
activation	NULL
__	NULL
the	NULL
action	NULL
of	NULL
two	NULL
signaling	NULL
pathways	NULL
:	NULL
(	NULL
a	NULL
)	NULL
a	NULL
Ca**+-dependent	NULL
by	NULL
CaMKIV/Gr	NULL
is	NULL
cyclosporin	NULL
A	NULL
resistant	NULL
,	NULL
whereas	NULL
the	NULL
_	NULL
pathway	NULL
involving	NULL
the	NULL
Ca**/calmodulin-dependent	NULL
phos-drug	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
blocks	NULL
PHA	NULL
induction	NULL
of	NULL
a	NULL
NFAT-	NULL
phatase	NULL
calcineurin	NULL
and	NULL
mediating	NULL
NFAT	NULL
'	NULL
c	NULL
translocation	NULL
to	NULL
106	NULL
Ca**	NULL
Signaling	NULL
Pathways	NULL
in	NULL
T	NULL
Lymphocytes	NULL
the	NULL
nucleus	NULL
(	NULL
43	NULL
)	NULL
;	NULL
and	NULL
(	NULL
b	NULL
)	NULL
a	NULL
PKC-	NULL
and	NULL
p21®-dependent	NULL
pathway	NULL
mediating	NULL
activation	NULL
of	NULL
AP-1	NULL
(	NULL
44	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
AP-~1	NULL
activation	NULL
by	NULL
CaMKIV/Gr	NULL
is	NULL
associated	NULL
with	NULL
increased	NULL
NFAT	NULL
activity	NULL
,	NULL
we	NULL
examined	NULL
if	NULL
CaMKIV/Gr	NULL
modulates	NULL
basal	NULL
and	NULL
mitogen-activated	NULL
transcription	NULL
from	NULL
a	NULL
NFAT-driven	NULL
repoter	NULL
gene	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
A	NULL
demonstrates	NULL
that	NULL
CaMKIV/Gr	NULL
upregulated	NULL
the	NULL
activation	NULL
of	NULL
NFAT	NULL
-dependent	NULL
transcription	NULL
by	NULL
PMA	NULL
and	NULL
the	NULL
Ca	NULL
#	NULL
*	NULL
ionophore	NULL
ionomycin	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
and	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
the	NULL
constitutively	NULL
active	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
moderately	NULL
inhibited	NULL
NFAT	NULL
activation	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
.	NULL

The	NULL
observed	NULL
synergy	NULL
between	NULL
CaMKIV/Gr	NULL
and	NULL
ionomycin	NULL
in	NULL
inducing	NULL
NFAT-dependent	NULL
transcription	NULL
is	NULL
of	NULL
interest	NULL
since	NULL
it	NULL
suggests	NULL
synergistic	NULL
interaction	NULL
between	NULL
calcinuerin	NULL
,	NULL
which	NULL
mediates	NULL
NFAT	NULL
'	NULL
c	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
CaMKIV/Gr	NULL
,	NULL
which	NULL
activates	NULL
AP-1	NULL
.	NULL

This	NULL
interpretation	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
previously	NULL
reported	NULL
capacity	NULL
of	NULL
transfected	NULL
AP~1	NULL
compo-nents	NULL
,	NULL
especially	NULL
c-fos	NULL
,	NULL
to	NULL
promote	NULL
NFAT	NULL
activation	NULL
by	NULL
ionomycin	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
line	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
NFAT-driven	NULL
transcription	NULL
,	NULL
CaMKIV/Gr	NULL
also	NULL
enhanced	NULL
the	NULL
transcriptional	NULL
activation	NULL
by	NULL
PMA	NULL
and	NULL
ionomycin	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
complete	NULL
IL-2	NULL
enhancer/promoter	NULL
and	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
more	NULL
pronounced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
suboptimal	NULL
concentrations	NULL
of	NULL
PMA	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
synergistic	NULL
induction	NULL
of	NULL
AP-1	NULL
by	NULL
PMA	NULL
and	NULL
CaMKIV/	NULL
Gr	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
.	NULL

A	NULL
1000	NULL
7	NULL
800	NULL
§	NULL
E	NULL
CJ	NULL
Medium	NULL
:	NULL
=	NULL
-	NULL
lonomycin	NULL
g	NULL
600	NULL
W	NULL
PMA+tonomycin	NULL
&	NULL
.	NULL

<	NULL
400	NULL
a	NULL
>	NULL
$	NULL
#	NULL
'	NULL
o	NULL
3	NULL
o	NULL
p	NULL
200	NULL
{	NULL
<	NULL
c	NULL
Hz	NULL
42	NULL
o	NULL
“	NULL
if	NULL
EC-	NULL
&	NULL
’	NULL
.	NULL

t	NULL
``	NULL
l	NULL
bet	NULL
=	NULL
&	NULL
=	NULL
%	NULL
2	NULL
=	NULL
=	NULL
x	NULL
w	NULL
x	NULL
3	NULL
§	NULL
00	NULL
8	NULL
0	NULL
g	NULL
§	NULL
5	NULL
a	NULL
B	NULL
3000	NULL
‘	NULL
|	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
Upregulation	NULL
of	NULL
NFAT	NULL
and	NULL
IL-2	NULL
enhancer/	NULL
5	NULL
promoter	NULL
activities	NULL
by	NULL
CaMKIV/Gr	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Jur-F	NULL
2000	NULL
-	NULL
kat	NULL
Tag	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
5	NULL
pg	NULL
of	NULL
NFAT	NULL
lu-B	NULL
Vector	NULL
ciferase	NULL
reporter	NULL
together	NULL
with	NULL
30	NULL
jug	NULL
of	NULL
pSGS5	NULL
vector	NULL
or	NULL
3	NULL
ACaMK	NULL
IV/Gr	NULL
(	NULL
c	NULL
)	NULL
pSG5	NULL
vector	NULL
containing	NULL
the	NULL
indicated	NULL
kinase	NULL
construct	NULL
.	NULL

E	NULL
{	NULL
CE	NULL
‘	NULL
MK	NULL
IWGr	NULL
(	NULL
i	NULL
)	NULL
The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
and	NULL
thereafter	NULL
treated	NULL
for	NULL
<	NULL
CaMK	NULL
Htc	NULL
}	NULL
6	NULL
h	NULL
with	NULL
either	NULL
medium	NULL
alone	NULL
,	NULL
ionomycin	NULL
at	NULL
1	NULL
pM	NULL
,	NULL
or	NULL
e	NULL
with	NULL
PMA	NULL
at	NULL
25	NULL
ng/ml	NULL
and	NULL
ionomycin	NULL
at	NULL
1	NULL
M.	NULL
Results	NULL
8	NULL
1000	NULL
-	NULL
are	NULL
means	NULL
of	NULL
three	NULL
experiments	NULL
+	NULL
SEM	NULL
and	NULL
are	NULL
expressed	NULL
.	NULL

$	NULL
as	NULL
fold	NULL
induction	NULL
over	NULL
values	NULL
obtained	NULL
with	NULL
empty	NULL
pSGS5	NULL
§	NULL
vector	NULL
alone	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
Tag	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
ert	NULL
an	NULL
IL-2	NULL
enhancer/promoter-driven	NULL
luciferase	NULL
reporter	NULL
=	NULL
gene	NULL
(	NULL
21	NULL
)	NULL
and	NULL
the	NULL
indicated	NULL
kinase	NULL
construct	NULL
and	NULL
incubated	NULL
as	NULL
above	NULL
;	NULL
they	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
at	NULL
1	NULL
a	NULL
-	NULL
pM	NULL
and	NULL
PMA	NULL
at	NULL
2.5	NULL
or	NULL
25	NULL
ng/ml	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Data	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

5	NULL
co	NULL
a	NULL
so	NULL
S	NULL
$	NULL
g	NULL
-	NULL
c	NULL
L	NULL
80	NULL
ri	NULL
Figure	NULL
7	NULL
.	NULL

-	NULL
Immunoblot	NULL
analysis	NULL
of	NULL
CaMKIV/	NULL
``	NULL
o	NULL
Gr	NULL
expression	NULL
in	NULL
Jurkat	NULL
,	NULL
BJAB	NULL
,	NULL
and	NULL
Hela	NULL
$	NULL
o	NULL
-	NULL
cells	NULL
.	NULL

100	NULL
pg	NULL
of	NULL
protein	NULL
lysates	NULL
derived	NULL
from	NULL
the	NULL
respective	NULL
cell	NULL
populations	NULL
was	NULL
resolved	NULL
by	NULL
SDS/PAGE	NULL
and	NULL
probed	NULL
for	NULL
endogenous	NULL
CaMKIV/Gr	NULL
using	NULL
a	NULL
polyclonal	NULL
rabbit	NULL
anti-human	NULL
CaMKIV/Gr	NULL
antiserum	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
Arrow	NULL
)	NULL
Position	NULL
of	NULL
the	NULL
two	NULL
CaMKIV/Gr	NULL
isoforms	NULL
.	NULL

Reconstitution	NULL
of	NULL
NFAT	NULL
-dependent	NULL
Transcription	NULL
in	NULL
Non-T	NULL
Cells	NULL
by	NULL
CaMKIV/Gr	NULL
and	NULL
NFATz	NULL
.	NULL

-	NULL
Endogenous	NULL
CaMKIV/	NULL
Gr	NULL
in	NULL
Jurkat	NULL
cells	NULL
is	NULL
activated	NULL
by	NULL
mitogens	NULL
and	NULL
is	NULL
thus	NULL
likely	NULL
to	NULL
mask	NULL
the	NULL
full	NULL
magnitude	NULL
of	NULL
NFAT	NULL
activation	NULL
by	NULL
recom-	NULL
B	NULL
um/NFATc	NULL
PMA/NFATe	NULL
@	NULL
OEO	NULL
IL-2	NULL
Luciferase	NULL
Activity	NULL
(	NULL
Fold	NULL
Induction	NULL
)	NULL
C	NULL
Hela	NULL
D	NULL
Medium	NULL
PMA	NULL
Medium/NFATc	NULL
PMA/NFATe	NULL
EGEO	NULL
IL-2	NULL
Luciferase	NULL
Activity	NULL
(	NULL
Fold	NULL
Induction	NULL
)	NULL
5	NULL
Ik	NULL
>	NULL
Figure	NULL
8.	NULL
binant	NULL
CaMKIV/Gr	NULL
transfectants	NULL
(	NULL
6	NULL
,	NULL
16	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
the	NULL
capacity	NULL
of	NULL
CaMKIV/Gr	NULL
transfectants	NULL
to	NULL
activate	NULL
NFAT	NULL
-dependent	NULL
transcription	NULL
in	NULL
non-T	NULL
cell	NULL
systems	NULL
that	NULL
lack	NULL
endogenous	NULL
CaMKIV/Gr	NULL
expression	NULL
.	NULL

Fig	NULL
.	NULL

7	NULL
demonstrates	NULL
that	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
,	NULL
the	NULL
human	NULL
B	NULL
cell	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
line	NULL
BJAB	NULL
(	NULL
11	NULL
)	NULL
and	NULL
the	NULL
human	NULL
cervical	NULL
adenocarcinoma	NULL
cell	NULL
line	NULL
HeLa	NULL
,	NULL
were	NULL
lacking	NULL
in	NULL
endogenous	NULL
CaMKIV/Gr	NULL
expression	NULL
,	NULL
as	NULL
detected	NULL
by	NULL
immunoblotting	NULL
with	NULL
a	NULL
specific	NULL
anti-human	NULL
CaMKIV/Gr	NULL
antiserum	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
cDNA	NULL
encoding	NULL
NFATc	NULL
and	NULL
CaMKIV/Gr	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
,	NULL
and	NULL
transcription	NULL
from	NULL
reporter	NULL
gene	NULL
constructs	NULL
driven	NULL
by	NULL
the	NULL
NFAT	NULL
response	NULL
element	NULL
or	NULL
by	NULL
the	NULL
complete	NULL
IL-2	NULL
enhancer/promoter	NULL
was	NULL
analyzed	NULL
.	NULL

Fig	NULL
.	NULL

8	NULL
A	NULL
demonstrates	NULL
that	NULL
a	NULL
construct	NULL
encoding	NULL
NFAT	NULL
c	NULL
was	NULL
ineffective	NULL
in	NULL
activating	NULL
transcription	NULL
of	NULL
the	NULL
NFAT	NULL
reporter	NULL
gene	NULL
in	NULL
BJAB	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
costimulus	NULL
.	NULL

Stimulation	NULL
with	NULL
PMA	NULL
resulted	NULL
in	NULL
a	NULL
modest	NULL
level	NULL
of	NULL
reporter	NULL
transcription	NULL
.	NULL

Transfection	NULL
of	NULL
BJAB	NULL
cells	NULL
with	NULL
a	NULL
construct	NULL
encoding	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
resulted	NULL
in	NULL
modest	NULL
activation	NULL
of	NULL
NFAT	NULL
BJAB	NULL
30	NULL
C	NULL
Medium	NULL
H	NULL
PMA	NULL
E	NULL
]	NULL
Medium/NFATe	NULL
L	NULL
PMANFATc	NULL
o	NULL
_L	NULL
,	NULL
20	NULL
ACaMK	NULL
HeLa	NULL
Medium	NULL
PMA	NULL
@	NULL
SEHO	NULL
e	NULL
aMKIVIGr	NULL
r	NULL
“	NULL
.|||_-_	NULL
'	NULL
AC	NULL
Reconstitution	NULL
of	NULL
NFAT	NULL
and	NULL
IL-2	NULL
promoter	NULL
activities	NULL
by	NULL
CaMKIV/Gr	NULL
and	NULL
NFAT	NULL
'	NULL
c	NULL
in	NULL
kinase-negative	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
10	NULL
``	NULL
BJAB	NULL
cells	NULL
were	NULL
cotransfected	NULL
by	NULL
electroporation	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
either	NULL
NFAT	NULL
or	NULL
IL-2	NULL
luciferase	NULL
reporters	NULL
and	NULL
30	NULL
fg	NULL
of	NULL
the	NULL
indicated	NULL
kinase	NULL
construct	NULL
with	NULL
or	NULL
without	NULL
an	NULL
additional	NULL
5	NULL
g	NULL
of	NULL
NFATe	NULL
cDNA	NULL
in	NULL
pBJ5	NULL
vector	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
and	NULL
then	NULL
treated	NULL
as	NULL
follows	NULL
and	NULL
left	NULL
incubating	NULL
for	NULL
an	NULL
additional	NULL
6	NULL
h	NULL
before	NULL
harvesting	NULL
.	NULL

(	NULL
Medium	NULL
)	NULL
Cells	NULL
receiving	NULL
kinase	NULL
construct	NULL
alone	NULL
and	NULL
otherwise	NULL
left	NULL
untreated	NULL
;	NULL
(	NULL
PMA	NULL
)	NULL
cells	NULL
receiving	NULL
kinase	NULL
construct	NULL
alone	NULL
and	NULL
treated	NULL
with	NULL
PMA	NULL
at	NULL
25	NULL
ng/ml	NULL
;	NULL
cells	NULL
cotransfected	NULL
with	NULL
NFATc	NULL
and	NULL
kinase	NULL
constructs	NULL
but	NULL
otherwise	NULL
left	NULL
untreated	NULL
;	NULL
(	NULL
PMA/NFAT	NULL
:	NULL
)	NULL
cells	NULL
cotransfected	NULL
with	NULL
NFATc	NULL
and	NULL
kinase	NULL
constructs	NULL
and	NULL
treated	NULL
with	NULL
PMA	NULL
at	NULL
25	NULL
ng/ml	NULL
.	NULL

Results	NULL
represent	NULL
mean	NULL
values	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
+	NULL
SEM	NULL
and	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
over	NULL
values	NULL
obtained	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
reporter	NULL
gene	NULL
and	NULL
empty	NULL
pSGS5	NULL
and	NULL
pBJ5	NULL
vectors	NULL
and	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
Hela	NULL
cells	NULL
were	NULL
cotransfected	NULL
by	NULL
the	NULL
Ca**	NULL
phosphate	NULL
method	NULL
with	NULL
2.5	NULL
jug	NULL
of	NULL
either	NULL
a	NULL
NFAT	NULL
or	NULL
a	NULL
IL-2	NULL
enhancer/	NULL
promoter-driven	NULL
reporter	NULL
gene	NULL
and	NULL
15	NULL
jug	NULL
of	NULL
the	NULL
indicated	NULL
kinase	NULL
construct	NULL
with	NULL
or	NULL
without	NULL
an	NULL
additional	NULL
2.5	NULL
ug	NULL
of	NULL
NFATc	NULL
cDNA	NULL
in	NULL
pBJ5	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
and	NULL
thereafter	NULL
treated	NULL
for	NULL
6	NULL
h	NULL
as	NULL
per	NULL
A	NULL
and	NULL
B	NULL
.	NULL

Results	NULL
represent	NULL
mean	NULL
values	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
+	NULL
SEM	NULL
.	NULL

108	NULL
Ca**	NULL
Signaling	NULL
Pathways	NULL
in	NULL
T	NULL
Lymphocytes	NULL
driven	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
induction	NULL
was	NULL
most	NULL
likely	NULL
mediated	NULL
by	NULL
endogenous	NULL
NFAT	NULL
proteins	NULL
normally	NULL
found	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
was	NULL
abrogated	NULL
upon	NULL
treatment	NULL
with	NULL
cyclosporin	NULL
A	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cotransfection	NULL
of	NULL
of	NULL
BJAB	NULL
cells	NULL
with	NULL
constructs	NULL
encoding	NULL
ACaMKIV/	NULL
Gr	NULL
(	NULL
c	NULL
)	NULL
and	NULL
NFATc	NULL
resulted	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NFAT-driven	NULL
reporter	NULL
gene	NULL
expression	NULL
to	NULL
levels	NULL
25-fold	NULL
higher	NULL
than	NULL
those	NULL
obtained	NULL
with	NULL
NFAT	NULL
'	NULL
c	NULL
alone	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
and	NULL
10-fold	NULL
higher	NULL
than	NULL
those	NULL
induced	NULL
upon	NULL
transfection	NULL
of	NULL
BJAB	NULL
cells	NULL
with	NULL
CaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
alone	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
NFAT	NULL
reporter	NULL
gene	NULL
expression	NULL
by	NULL
NFATc	NULL
and	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
was	NULL
further	NULL
upregulated	NULL
by	NULL
PMA	NULL
by	NULL
about	NULL
twofold	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
observed	NULL
synergy	NULL
between	NULL
PMA/Ras	NULL
and	NULL
CaMKIV/Gr	NULL
in	NULL
upregulating	NULL
AP-1	NULL
function	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
in	NULL
BJAB	NULL
cells	NULL
were	NULL
reproduced	NULL
in	NULL
the	NULL
human	NULL
adenocarcinoma	NULL
cell	NULL
line	NULL
Hela	NULL
.	NULL

Fig	NULL
.	NULL

8	NULL
C	NULL
demonstrates	NULL
that	NULL
a	NULL
construct	NULL
encoding	NULL
NFAT	NULL
'	NULL
c	NULL
was	NULL
ineffective	NULL
in	NULL
activating	NULL
transcription	NULL
of	NULL
the	NULL
NFAT	NULL
reporter	NULL
gene	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
transfection	NULL
of	NULL
a	NULL
construct	NULL
encoding	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
failed	NULL
to	NULL
activate	NULL
NFAT	NULL
-driven	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cotransfection	NULL
of	NULL
HeLa	NULL
cells	NULL
with	NULL
constructs	NULL
encoding	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
and	NULL
NFATc	NULL
resulted	NULL
in	NULL
vigorous	NULL
activation	NULL
of	NULL
NFAT	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
NFAT	NULL
reporter	NULL
gene	NULL
expression	NULL
by	NULL
NFAT	NULL
'	NULL
c	NULL
and	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
was	NULL
further	NULL
upregulated	NULL
by	NULL
PMA	NULL
,	NULL
similar	NULL
to	NULL
what	NULL
was	NULL
observed	NULL
with	NULL
BJAB	NULL
cells	NULL
.	NULL

The	NULL
validity	NULL
of	NULL
these	NULL
results	NULL
was	NULL
extended	NULL
to	NULL
an	NULL
IL-2	NULL
enhancer/promoter-driven	NULL
luciferase	NULL
reporter	NULL
gene	NULL
,	NULL
where	NULL
ACaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
was	NULL
found	NULL
to	NULL
synergize	NULL
with	NULL
NFATc	NULL
to	NULL
drive	NULL
the	NULL
transcription	NULL
of	NULL
this	NULL
reporter	NULL
in	NULL
both	NULL
BJAB	NULL
and	NULL
Hela	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
B	NULL
and	NULL
D	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
CaMKIV/Gr	NULL
stimulation	NULL
of	NULL
NFAT	NULL
'	NULL
c	NULL
activity	NULL
in	NULL
BJAB	NULL
and	NULL
HeLa	NULL
cells	NULL
was	NULL
suggested	NULL
by	NULL
the	NULL
failure	NULL
of	NULL
CaMKII	NULL
(	NULL
c	NULL
)	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
the	NULL
analyzed	NULL
reporter	NULL
genes	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
by	NULL
which	NULL
CaMKIV/Gr	NULL
{	NULL
(	NULL
c	NULL
)	NULL
synergized	NULL
with	NULL
NFAT	NULL
'	NULL
c	NULL
in	NULL
inducing	NULL
NFAT	NULL
and	NULL
IL-2	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
non-T	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
transfected	NULL
HeLa	NULL
cells	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
NFAT	NULL
DNA-binding	NULL
activity	NULL
using	NULL
an	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
distal	NULL
NFAT	NULL
site	NULL
in	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
.	NULL

This	NULL
oligonucleotide	NULL
binds	NULL
to	NULL
NFAT	NULL
proteins	NULL
both	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
associated	NULL
AP-1	NULL
components	NULL
to	NULL
give	NULL
rise	NULL
to	NULL
two	NULL
distinct	NULL
DNA-protein	NULL
complexes	NULL
that	NULL
can	NULL
be	NULL
resolved	NULL
on	NULL
PAGE	NULL
:	NULL
a	NULL
faster	NULL
migrating	NULL
complex	NULL
containing	NULL
NFAT	NULL
and	NULL
a	NULL
slower	NULL
complex	NULL
containing	NULL
NFAT/AP-1	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

9	NULL
demonstrates	NULL
that	NULL
nuclear	NULL
extracts	NULL
of	NULL
HeLa	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
transfected	NULL
with	NULL
empty	NULL
vectors	NULL
alone	NULL
exhibited	NULL
no	NULL
NFAT	NULL
-specific	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

Transfection	NULL
with	NULL
NFAT	NULL
'	NULL
c	NULL
induced	NULL
the	NULL
appearance	NULL
of	NULL
two	NULL
NFAT	NULL
-specific	NULL
complexes	NULL
:	NULL
a	NULL
dominant	NULL
,	NULL
higher	NULL
mobility	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
arrow	NULL
)	NULL
and	NULL
a	NULL
minor	NULL
slower	NULL
moving	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
arrowhead	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
cyclosporin	NULL
A	NULL
,	NULL
indicating	NULL
that	NULL
recombinant	NULL
NFATc	NULL
gained	NULL
entry	NULL
into	NULL
nuclei	NULL
of	NULL
un-stimulated	NULL
HeLa	NULL
cells	NULL
by	NULL
a	NULL
calcineurin-independent	NULL
mechanism	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
CaMKIV/Gr	NULL
(	NULL
c	NULL
)	NULL
induced	NULL
no	NULL
demonstrable	NULL
NFAT	NULL
-specific	NULL
binding	NULL
activity	NULL
.	NULL

In	NULL
109	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

-	NULL
A.	NULL
T0	NULL
T	NULL
«	NULL
4	NULL
j	NULL
o	NULL
.	NULL

Competitor	NULL
|	NULL
-	NULL
L.	NULL
L	NULL
o-	NULL
-	NULL
&	NULL
&	NULL
g	NULL
o	NULL
o	NULL
=	NULL
o	NULL
_	NULL
EoE	NULL
E	NULL
E	NULL
<	NULL
0	NULL
40	NULL
<	NULL
0	NULL
<	NULL
o	NULL
L	NULL
o	NULL
o	NULL
l	NULL
2	NULL
Z	NULL
Z	NULL
Z	NULL
£	NULL
to	NULL
%	NULL
o	NULL
+	NULL
bo	NULL
m	NULL
m	NULL
m	NULL
s	NULL
Yo	NULL
0	NULL
o	NULL
°	NULL
v	NULL
=	NULL
9	NULL
To	NULL
y	NULL
yo	NULL
y	NULL
y	NULL
U	NULL
$	NULL
o	NULL
wo	NULL
wo	NULL
W	NULL
Ro	NULL
m	NULL
m	NULL
Om	NULL
om	NULL
c	NULL
=	NULL
3	NULL
3	NULL
Fo	NULL
F	NULL
Yo	NULL
yoyo	NULL
xo	NULL
z	NULL
30	NULL
8	NULL
Ao	NULL
s	NULL
S	NULL
§	NULL
S	NULL
%	NULL
ouqmmmmm	NULL
20	NULL
8	NULL
u_	NULL
YQ	NULL
9	NULL
Q	NULL
0	NULL
Q0	NULL
UJ	NULL
a	NULL
>	NULL
Z	NULL
<	NULL
4	NULL
4	NULL
4	NULL
4	NULL
4	NULL
I4	NULL
lud	NULL
bd	NULL
-	NULL
buh	NULL
Wid	NULL
~dutimqgtwt	NULL
h	NULL
|	NULL
Figure	NULL
9	NULL
.	NULL

-	NULL
Upregulation	NULL
of	NULL
NFAT	NULL
DNA-binding	NULL
activity	NULL
by	NULL
CaMKIV/	NULL
Gr	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
HeLa	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
construct	NULL
(	NULL
s	NULL
)	NULL
as	NULL
detailed	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

5	NULL
jg	NULL
of	NULL
the	NULL
respective	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
*°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
murine	NULL
IL-2	NULL
distal	NULL
NFAT	NULL
site	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
or	NULL
mutant	NULL
AP-1	NULL
(	NULL
mAP1	NULL
)	NULL
competitor	NULL
oligonucleotide	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
bound	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
5	NULL
%	NULL
nondenaturing	NULL
acrylamide	NULL
gel	NULL
.	NULL

(	NULL
Probe	NULL
lane	NULL
)	NULL
Radiolabeled	NULL
reaction	NULL
mixture	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

(	NULL
Arrowhead	NULL
)	NULL
DNA	NULL
complexes	NULL
containing	NULL
NFAT	NULL
proteins	NULL
together	NULL
with	NULL
AP-1	NULL
;	NULL
(	NULL
arrow	NULL
)	NULL
complexes	NULL
containing	NULL
NFAT	NULL
proteins	NULL
.	NULL

The	NULL
bottom	NULL
two	NULL
bands	NULL
represents	NULL
nonspecific	NULL
DNA-protein	NULL
complex	NULL
,	NULL
while	NULL
unbound	NULL
radiolabeled	NULL
probe	NULL
was	NULL
allowed	NULL
to	NULL
run	NULL
out	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

contrast	NULL
,	NULL
cotransfection	NULL
of	NULL
both	NULL
NFATc	NULL
and	NULL
CaMKIV/Gr	NULL
{	NULL
(	NULL
c	NULL
)	NULL
resulted	NULL
in	NULL
marked	NULL
increase	NULL
in	NULL
the	NULL
upper	NULL
complex	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
activity	NULL
by	NULL
CaMKIV/Gr	NULL
.	NULL

It	NULL
also	NULL
resulted	NULL
in	NULL
some	NULL
increase	NULL
in	NULL
the	NULL
abundance	NULL
of	NULL
the	NULL
lower	NULL
complex	NULL
,	NULL
consistent	NULL
with	NULL
either	NULL
enhanced	NULL
transport	NULL
of	NULL
NFATc	NULL
into	NULL
the	NULL
nucleus	NULL
and/or	NULL
increased	NULL
retention	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
NFAT-DNA	NULL
complexes	NULL
was	NULL
ascertained	NULL
by	NULL
the	NULL
capacity	NULL
of	NULL
excess	NULL
unlabeled	NULL
NFAT-binding	NULL
oligonucleotide	NULL
to	NULL
competitively	NULL
inhibit	NULL
both	NULL
NFAT-DNA	NULL
complexes	NULL
.	NULL

Addition	NULL
of	NULL
excess	NULL
unlabeled	NULL
AP-1-binding	NULL
oligonucleotide	NULL
specifically	NULL
inhibited	NULL
the	NULL
upper	NULL
complex	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
AP-1	NULL
in	NULL
that	NULL
complex	NULL
,	NULL
whereas	NULL
mutant	NULL
AP-1-binding	NULL
oligonucleotide	NULL
,	NULL
which	NULL
exhibits	NULL
poor	NULL
affinity	NULL
to	NULL
AP-1	NULL
,	NULL
inhibited	NULL
neither	NULL
complex	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
CaMKIV/Gr	NULL
{	NULL
(	NULL
c	NULL
)	NULL
on	NULL
NFAT	NULL
-driven	NULL
transcription	NULL
could	NULL
be	NULL
accounted	NULL
for	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
the	NULL
capacity	NULL
of	NULL
the	NULL
kinase	NULL
to	NULL
activate	NULL
AP-1	NULL
expression	NULL
.	NULL

Discussion	NULL
The	NULL
present	NULL
study	NULL
establishes	NULL
the	NULL
role	NULL
of	NULL
CaMKIV/Gr	NULL
as	NULL
a	NULL
transducer	NULL
of	NULL
Ca**-dependent	NULL
activation	NULL
signals	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

CaMKIV/Gr	NULL
upregulates	NULL
NFAT	NULL
and	NULL
IL-2	NULL
enhancer/promoter-dependent	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
,	NULL
importantly	NULL
,	NULL
reconstitutes	NULL
the	NULL
capacity	NULL
of	NULL
NFAT	NULL
'	NULL
c	NULL
to	NULL
direct	NULL
transcription	NULL
from	NULL
the	NULL
respective	NULL
regulatory	NULL
sequence	NULL
in	NULL
non-T	NULL
cells	NULL
The	NULL
promotion	NULL
by	NULL
CaMKIV/Gr	NULL
of	NULL
NFAT	NULL
and	NULL
IL-2	NULL
enhancer/promoter-dependent	NULL
transcription	NULL
is	NULL
due	NULL
in	NULL
part	NULL
to	NULL
the	NULL
induction	NULL
by	NULL
the	NULL
kinase	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
example	NULL
of	NULL
AP-1	NULL
activation	NULL
by	NULL
a	NULL
CaMK	NULL
,	NULL
and	NULL
the	NULL
results	NULL
herein	NULL
provide	NULL
a	NULL
novel	NULL
mechanism	NULL
by	NULL
which	NULL
Ca**	NULL
signaling	NULL
upregulates	NULL
AP~1	NULL
function	NULL
.	NULL

CaMKIV/Gr	NULL
induces	NULL
AP-1	NULL
in	NULL
part	NULL
by	NULL
activating	NULL
the	NULL
transcription	NULL
of	NULL
genes	NULL
encoding	NULL
AP-1	NULL
components	NULL
.	NULL

This	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
demonstration	NULL
that	NULL
CaMKIV/Gr	NULL
upregulates	NULL
the	NULL
transcription	NULL
in	NULL
Jurkat	NULL
cells	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
c-fos	NULL
promoter/enhancer	NULL
and	NULL
by	NULL
the	NULL
demonstration	NULL
that	NULL
CaMKIV/Gr	NULL
induces	NULL
the	NULL
transcription	NULL
of	NULL
c-fos	NULL
in	NULL
PC12	NULL
rat	NULL
pheochromocytoma	NULL
cells	NULL
.	NULL

CaMKIV/Gr	NULL
induction	NULL
of	NULL
c-fos	NULL
transcription	NULL
proceeds	NULL
by	NULL
a	NULL
serum	NULL
response	NULL
factor-dependent	NULL
mechanism	NULL
in	NULL
contrast	NULL
to	NULL
induction	NULL
by	NULL
p21'®	NULL
,	NULL
which	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
serum	NULL
response	NULL
factor-associated	NULL
protein	NULL
Elk-1	NULL
(	NULL
45	NULL
)	NULL
.	NULL

This	NULL
illustrates	NULL
how	NULL
CaMKIV/Gr	NULL
and	NULL
p21	NULL
``	NULL
®	NULL
can	NULL
act	NULL
independently	NULL
yet	NULL
synergistically	NULL
to	NULL
upregulate	NULL
AP-1	NULL
function	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
CaMKIV/Gr	NULL
activates	NULL
transcription	NULL
of	NULL
genes	NULL
encoding	NULL
other	NULL
AP-1	NULL
components	NULL
and	NULL
whether	NULL
it	NULL
additionally	NULL
upregulates	NULL
AP-1	NULL
activity	NULL
by	NULL
a	NULL
posttranscriptional	NULL
mechanism	NULL
.	NULL

Consistent	NULL
with	NULL
its	NULL
induction	NULL
of	NULL
AP-1	NULL
,	NULL
CaMKIV/Gr	NULL
upregulated	NULL
the	NULL
activation	NULL
by	NULL
mitogens	NULL
of	NULL
NFAT-dependent	NULL
transcription	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

It	NULL
also	NULL
synergized	NULL
with	NULL
recombinant	NULL
NFAT	NULL
'	NULL
c	NULL
in	NULL
promoting	NULL
NFAT	NULL
-dependent	NULL
transcription	NULL
in	NULL
BJAB	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
latter	NULL
case	NULL
,	NULL
NFAT	NULL
'	NULL
c	NULL
gained	NULL
entry	NULL
into	NULL
the	NULL
nucleus	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
Ca**-mobilizing	NULL
signal	NULL
.	NULL

This	NULL
probably	NULL
resulted	NULL
from	NULL
overexpression	NULL
of	NULL
NFATc	NULL
in	NULL
the	NULL
cytosol	NULL
leading	NULL
to	NULL
its	NULL
transport	NULL
into	NULL
the	NULL
nucleus	NULL
in	NULL
a	NULL
calcineurin-independent	NULL
manner	NULL
.	NULL

Whereas	NULL
AP~-1	NULL
induction	NULL
provides	NULL
an	NULL
important	NULL
mechanism	NULL
underlying	NULL
the	NULL
activation	NULL
of	NULL
IL-2	NULL
transcription	NULL
by	NULL
CaMKIV/Gr	NULL
,	NULL
additional	NULL
kinase-induced	NULL
activation	NULL
events	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
.	NULL

This	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
CaMKIV/Gr	NULL
greatly	NULL
surpassed	NULL
PMA	NULL
in	NULL
activating	NULL
transcription	NULL
of	NULL
NFAT	NULL
and	NULL
IL-2	NULL
enhancer/promoter-driven	NULL
reporter	NULL
genes	NULL
in	NULL
non-T	NULL
cells	NULL
.	NULL

An	NULL
effect	NULL
on	NULL
NFAT	NULL
'	NULL
c	NULL
itself	NULL
is	NULL
possible	NULL
,	NULL
suggested	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
CaMKIV/Gr	NULL
increased	NULL
NFAT	NULL
DNA-binding	NULL
activity	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
NFATc	NULL
(	NULL
26	NULL
)	NULL
and	NULL
its	NULL
related	NULL
factors	NULL
NFAT	NULL
(	NULL
46	NULL
)	NULL
,	NULL
NFATc3	NULL
(	NULL
47	NULL
)	NULL
,	NULL
and	NULL
NFAT-X	NULL
(	NULL
48	NULL
)	NULL
contain	NULL
numerous	NULL
consensus	NULL
phosphorylation	NULL
sites	NULL
for	NULL
CaMKIV/Gr	NULL
and	NULL
CaMKII	NULL
.	NULL

The	NULL
role	NULL
of	NULL
these	NULL
phosphorylation	NULL
sites	NULL
in	NULL
positive	NULL
and	NULL
negative	NULL
regulation	NULL
of	NULL
NFAT	NULL
protein	NULL
function	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
activation	NULL
of	NULL
NFAT	NULL
-dependent	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
a	NULL
cooperative	NULL
process	NULL
between	NULL
several	NULL
signaling	NULL
pathways	NULL
and	NULL
that	NULL
it	NULL
involves	NULL
calcineurin	NULL
,	NULL
CaMKIV/	NULL
Gr	NULL
,	NULL
and	NULL
PKC-	NULL
and	NULL
p21	NULL
``	NULL
®-dependent	NULL
pathways	NULL
.	NULL

However	NULL
,	NULL
unlike	NULL
the	NULL
aforementioned	NULL
transducers	NULL
of	NULL
TCR	NULL
signaling	NULL
,	NULL
CaMKIV/Gr	NULL
is	NULL
distinguished	NULL
by	NULL
its	NULL
selective	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
particularly	NULL
the	NULL
CD4*	NULL
subset	NULL
(	NULL
6	NULL
)	NULL
.	NULL

This	NULL
and	NULL
the	NULL
capacity	NULL
of	NULL
CaMKIV/Gr	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
lymphokine	NULL
response	NULL
elements	NULL
suggests	NULL
that	NULL
the	NULL
kinase	NULL
may	NULL
be	NULL
an	NULL
important	NULL
determinant	NULL
of	NULL
the	NULL
type	NULL
and	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
lymphokine	NULL
genes	NULL
present	NULL
in	NULL
T	NULL
versus	NULL
B	NULL
cells	NULL
and	NULL
possibly	NULL
among	NULL
different	NULL
T	NULL
cell	NULL
populations	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
salutary	NULL
effects	NULL
of	NULL
CaMKIV/Gr	NULL
on	NULL
transcription	NULL
directed	NULL
from	NULL
lymphokine	NULL
regulatory	NULL
ele-ments	NULL
,	NULL
the	NULL
multifunctional	NULL
CaMKII-yp	NULL
inhibits	NULL
transcription	NULL
from	NULL
these	NULL
same	NULL
elements	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
CaMKII	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
mediating	NULL
negative	NULL
effects	NULL
of	NULL
Ca**	NULL
signaling	NULL
in	NULL
lymphocytes	NULL
,	NULL
including	NULL
anergy	NULL
and	NULL
negative	NULL
selection	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
outcome	NULL
of	NULL
Ca**	NULL
signaling	NULL
in	NULL
a	NULL
particular	NULL
T	NULL
lymphocyte	NULL
is	NULL
more	NULL
likely	NULL
to	NULL
be	NULL
determined	NULL
by	NULL
a	NULL
complex	NULL
set	NULL
of	NULL
interactions	NULL
between	NULL
the	NULL
various	NULL
Ca**-responsive	NULL
enzymes	NULL
,	NULL
including	NULL
CaMKIV/Gr	NULL
,	NULL
CaMKII	NULL
,	NULL
and	NULL
calcineurin	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
each	NULL
of	NULL
these	NULL
enzymes	NULL
to	NULL
the	NULL
diverse	NULL
effects	NULL
of	NULL
Ca**	NULL
signaling	NULL
in	NULL
T	NULL
lymphocytes	NULL
remains	NULL
to	NULL
be	NULL
fully	NULL
mapped	NULL
.	NULL

We	NULL
thank	NULL
D.	NULL
Cantrell	NULL
,	NULL
K.	NULL
Chien	NULL
,	NULL
G.	NULL
Crabtree	NULL
,	NULL
M.	NULL
Greenberg	NULL
,	NULL
K.	NULL
Murphy	NULL
,	NULL
and	NULL
H.	NULL
Schulman	NULL
for	NULL
generous	NULL
gifts	NULL
of	NULL
reagents	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
J.	NULL
Gitlin	NULL
,	NULL
C.	NULL
Tripp	NULL
,	NULL
and	NULL
E.	NULL
Unanue	NULL
for	NULL
discussions	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
Talal	NULL
Chatila	NULL
,	NULL
Division	NULL
of	NULL
Immunology	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
1	NULL
Children	NULL
's	NULL
Place	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
63110	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
22	NULL
November	NULL
1995	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
19	NULL
March	NULL
1996	NULL
.	NULL

References	NULL
1	NULL
.	NULL

O'Keefe	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
J.	NULL
Tamura	NULL
,	NULL
RL	NULL
.	NULL

Kincaid	NULL
,	NULL
M.J.	NULL
Tocci	NULL
,	NULL
and	NULL
E.A	NULL
.	NULL

O'Neill	NULL
,	NULL
1992	NULL
.	NULL

FK-506	NULL
and	NULL
CsA-sensitive	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
by	NULL
calcenurin	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

357	NULL
:	NULL
692-694	NULL
.	NULL

2	NULL
.	NULL

Clipstone	NULL
,	NULL
N.A	NULL
.	NULL

,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
calcineurin	NULL
as	NULL
a	NULL
key	NULL
signaling	NULL
enzyme	NULL
in	NULL
T	NULL
lymphocyte	NULL
acti-	NULL
110	NULL
Signaling	NULL
Pathways	NULL
in	NULL
T	NULL
Lymphocytes	NULL
vation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

357:695-697.	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
J.D	NULL
.	NULL

Farmer	NULL
,	NULL
W.S	NULL
.	NULL

Lane	NULL
,	NULL
J.	NULL
Friedman	NULL
,	NULL
I.	NULL
Weissman	NULL
,	NULL
and	NULL
S.L	NULL
.	NULL

Schreiber	NULL
.	NULL

1991	NULL
.	NULL

Calcineurin	NULL
is	NULL
a	NULL
common	NULL
target	NULL
of	NULL
cyclophilin-cyclosporin	NULL
A	NULL
and	NULL
FKBP-FK506	NULL
complexes	NULL
.	NULL

Cell	NULL
.	NULL

66:807-815.	NULL
.	NULL

Hanson	NULL
,	NULL
P.L	NULL
.	NULL

,	NULL
and	NULL
H.	NULL
Schulman	NULL
.	NULL

1992	NULL
.	NULL

Neuronal	NULL
Ca**/cal-	NULL
modulin-dependent	NULL
protein	NULL
kinases	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

61	NULL
:	NULL
559-601.	NULL
.	NULL

Frangakis	NULL
,	NULL
M.V	NULL
.	NULL

,	NULL
T.	NULL
Chatila	NULL
,	NULL
ER	NULL
.	NULL

Wood	NULL
,	NULL
and	NULL
N.	NULL
Sahyoun	NULL
.	NULL

1991	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
neuronal	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
,	NULL
CaM	NULL
kinase-Gr	NULL
,	NULL
in	NULL
rat	NULL
thymus	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:17592-17596.	NULL
.	NULL

Hanissian	NULL
,	NULL
S.H	NULL
.	NULL

,	NULL
M.	NULL
Frangakis	NULL
,	NULL
M.M	NULL
.	NULL

Bland	NULL
,	NULL
S.	NULL
Jawahar	NULL
,	NULL
and	NULL
T.A	NULL
.	NULL

Chatila	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
Ca**/calmodulin	NULL
dependent	NULL
protein	NULL
kinase	NULL
,	NULL
CaM	NULL
kinase-Gr	NULL
,	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Regulation	NULL
of	NULL
kinase	NULL
activity	NULL
by	NULL
T	NULL
cell	NULL
receptor	NULL
signal-ing	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:20055-20063.	NULL
.	NULL

Ohmstede	NULL
,	NULL
C.-A	NULL
.	NULL

,	NULL
M.M	NULL
.	NULL

Bland	NULL
,	NULL
B.M	NULL
.	NULL

Merrill	NULL
,	NULL
and	NULL
N.	NULL
Sahyoun	NULL
.	NULL

1991	NULL
.	NULL

Relationship	NULL
of	NULL
genes	NULL
encoding	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
Gr	NULL
and	NULL
calspermin	NULL
:	NULL
a	NULL
gene	NULL
within	NULL
a	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

88:5784-5788.	NULL
.	NULL

Means	NULL
,	NULL
A.R	NULL
.	NULL

,	NULL
F.	NULL
Cruzalegui	NULL
,	NULL
B.	NULL
LeMagueresse	NULL
,	NULL
D.S	NULL
.	NULL

Needle	NULL
man	NULL
,	NULL
GR	NULL
.	NULL

Slaughter	NULL
,	NULL
and	NULL
T.	NULL
Ono	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
novel	NULL
Ca	NULL
#	NULL
+*+/	NULL
calmodulin-dependent	NULL
protein	NULL
kinase	NULL
and	NULL
a	NULL
male	NULL
germ	NULL
cell-specific	NULL
calmodulin-binding	NULL
protein	NULL
are	NULL
derived	NULL
from	NULL
the	NULL
same	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:3960-3971.	NULL
.	NULL

Sikela	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
ML	NULL
.	NULL

Law	NULL
,	NULL
F.-T.	NULL
Kao	NULL
,	NULL
JA	NULL
.	NULL

Hartz	NULL
,	NULL
Q.	NULL
Wei	NULL
,	NULL
and	NULL
W.H	NULL
.	NULL

Hahn	NULL
.	NULL

1989	NULL
.	NULL

Chromosomal	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
for	NULL
brain	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
type	NULL
IV	NULL
.	NULL

Genomics	NULL
.	NULL

4:21-27	NULL
.	NULL

10	NULL
.	NULL

Jones	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
J.	NULL
Glod	NULL
,	NULL
D.	NULL
Wilson-Shaw	NULL
,	NULL
W.E	NULL
.	NULL

Hahn	NULL
,	NULL
and	NULL
J.M	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

Sikela	NULL
.	NULL

1991.	NULL
cDNA	NULL
sequence	NULL
and	NULL
differential	NULL
expression	NULL
of	NULL
the	NULL
mouse	NULL
Ca**/calmodulin	NULL
dependent	NULL
protein	NULL
kinase	NULL
IV	NULL
gene	NULL
.	NULL

FEBS	NULL
(	NULL
Fed	NULL
.	NULL

Eur	NULL
.	NULL

Biochem	NULL
.	NULL

Soc	NULL
.	NULL
)	NULL

Lett	NULL
.	NULL

289:105-109	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
S.H	NULL
.	NULL

Hanissian	NULL
,	NULL
S.	NULL
Jawahar	NULL
,	NULL
L.	NULL
Vara	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
T.A	NULL
.	NULL

Chatila	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
Ca®*/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
,	NULL
CaM	NULL
kinase-Gr	NULL
,	NULL
expressed	NULL
after	NULL
transformation	NULL
of	NULL
primary	NULL
human	NULL
B	NULL
lymphocytes	NULL
by	NULL
the	NULL
Epstein	NULL
Barr	NULL
virus	NULL
{	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
induced	NULL
by	NULL
the	NULL
EBV	NULL
oncogene	NULL
LMP1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68	NULL
:	NULL
1697-1705	NULL
.	NULL

Mathews	NULL
,	NULL
RP	NULL
.	NULL

,	NULL
C.R	NULL
.	NULL

Guthrie	NULL
,	NULL
LM	NULL
.	NULL

Wailes	NULL
,	NULL
X.	NULL
Zhao	NULL
,	NULL
A.R	NULL
.	NULL

Means	NULL
,	NULL
and	NULL
G.S	NULL
.	NULL

Mcknight	NULL
.	NULL

1994	NULL
.	NULL

Calcium/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
types	NULL
II	NULL
and	NULL
IV	NULL
differentially	NULL
regulate	NULL
CREB-dependent	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
:	NULL
6107-6116	NULL
.	NULL

Cruzalegui	NULL
,	NULL
FH	NULL
.	NULL

,	NULL
and	NULL
A.R	NULL
.	NULL

Means	NULL
.	NULL

1993	NULL
.	NULL

Biochemical	NULL
characterization	NULL
of	NULL
the	NULL
multifunctional	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
type	NULL
IV	NULL
expressed	NULL
in	NULL
insect	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:26171-26178	NULL
.	NULL

Enslen	NULL
,	NULL
H.	NULL
,	NULL
P.	NULL
Sun	NULL
,	NULL
D.	NULL
Brickey	NULL
,	NULL
S.H	NULL
.	NULL

Soderling	NULL
,	NULL
E.	NULL
Klamo	NULL
,	NULL
and	NULL
TR	NULL
.	NULL

Soderling	NULL
.	NULL

1994	NULL
.	NULL

Characterization	NULL
of	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
IV	NULL
.	NULL

Role	NULL
in	NULL
transcriptional	NULL
regulation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:15520-15527	NULL
.	NULL

Sun	NULL
,	NULL
P.	NULL
,	NULL
H.	NULL
Enslen	NULL
,	NULL
P.S	NULL
.	NULL

Myung	NULL
,	NULL
and	NULL
R.A.	NULL
Maurer	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
activation	NULL
of	NULL
CREB	NULL
by	NULL
Ca®*/calmodulin-dependent	NULL
protein	NULL
kinases	NULL
type	NULL
II	NULL
and	NULL
type	NULL
IV	NULL
involves	NULL
phosphorylation	NULL
of	NULL
a	NULL
site	NULL
that	NULL
negatively	NULL
regulates	NULL
activity	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

8:2527-2539	NULL
.	NULL

Marklund	NULL
,	NULL
U.	NULL
,	NULL
N.	NULL
Larson	NULL
,	NULL
G.	NULL
Brattsand	NULL
,	NULL
O.	NULL
Osterman	NULL
,	NULL
T.A	NULL
.	NULL

Chatila	NULL
,	NULL
and	NULL
M.	NULL
Gullberg	NULL
.	NULL

1994	NULL
.	NULL

Serine	NULL
16	NULL
of	NULL
oncoprotein	NULL
18	NULL
is	NULL
a	NULL
major	NULL
cytosolic	NULL
target	NULL
for	NULL
the	NULL
Ca**/calmodulin-dependent	NULL
kinase-Gr	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

225:53-60	NULL
.	NULL

Park	NULL
,	NULL
L-K.	NULL
,	NULL
and	NULL
TR	NULL
.	NULL

Soderling	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
Ca**/	NULL
111	NULL
Ho	NULL
et	NULL
al	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32.	NULL
calmodulin-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
CaM-kinase	NULL
)	NULL
IV	NULL
by	NULL
CaM-kinase	NULL
kinase	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
30464-30469	NULL
.	NULL

Selbert	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
K.A	NULL
.	NULL

Anderson	NULL
,	NULL
Q.H	NULL
.	NULL

Huang	NULL
,	NULL
E.g	NULL
.	NULL

,	NULL
Goldstein	NULL
,	NULL
AR	NULL
.	NULL

Means	NULL
,	NULL
and	NULL
A.M.	NULL
Edelman	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
Ca	NULL
@	NULL
*	NULL
)	NULL
-calmodulin-dependent	NULL
protein	NULL
kinase	NULL
IV	NULL
by	NULL
Ca	NULL
@	NULL
P-calmodulin-dependent	NULL
protein	NULL
kinase	NULL
Ia	NULL
kinase	NULL
.	NULL

Phosphorylation	NULL
of	NULL
threonine	NULL
196	NULL
is	NULL
essential	NULL
for	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:17616-17621	NULL
.	NULL

Nickoloff	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
and	NULL
W.P	NULL
.	NULL

Deng	NULL
.	NULL

1992	NULL
.	NULL

Site-directed	NULL
mu-tagenesis	NULL
of	NULL
virtually	NULL
any	NULL
plasmid	NULL
by	NULL
eliminating	NULL
a	NULL
unique	NULL
site	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

200:81-88	NULL
.	NULL

Nghiem	NULL
,	NULL
P.	NULL
,	NULL
S.M	NULL
.	NULL

Saati	NULL
,	NULL
C.L	NULL
.	NULL

Martens	NULL
,	NULL
P.	NULL
Gardner	NULL
,	NULL
and	NULL
H.	NULL
Schulman	NULL
.	NULL

1993	NULL
.	NULL

Cloning	NULL
and	NULL
analysis	NULL
of	NULL
two	NULL
new	NULL
isoforms	NULL
of	NULL
multifunctional	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:5471-5479	NULL
.	NULL

Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
K.S	NULL
.	NULL

Ullman	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
lymphoid-specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:2917-2923	NULL
.	NULL

Hattori	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Tugores	NULL
,	NULL
J.	NULL
Westwick	NULL
,	NULL
L.	NULL
Veloz	NULL
,	NULL
H.L	NULL
.	NULL

Leffert	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
D.A	NULL
.	NULL

Brenner	NULL
.	NULL

1993	NULL
.	NULL

Activation	NULL
of	NULL
activating	NULL
protein	NULL
1	NULL
during	NULL
hepatic	NULL
acute	NULL
phase	NULL
response	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

264	NULL
:	NULL
G-95-G103	NULL
.	NULL

Szabo	NULL
,	NULL
SJ	NULL
.	NULL

,	NULL
J.S	NULL
.	NULL

Gold	NULL
,	NULL
TL	NULL
.	NULL

Murphy	NULL
,	NULL
and	NULL
K.M	NULL
.	NULL

Murphy	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
cis-acting	NULL
regulatory	NULL
element	NULL
controlling	NULL
interleukin-4	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
roles	NULL
for	NULL
NF-Y	NULL
and	NULL
NF-AT	NULL
'	NULL
c	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4793-4805	NULL
.	NULL

Gilman	NULL
,	NULL
MZ	NULL
.	NULL

,	NULL
R.N	NULL
.	NULL

Wilson	NULL
,	NULL
and	NULL
R.A.	NULL
Weinberg	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
protein-binding	NULL
sites	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
regulate	NULL
c-fos	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:4305-4316	NULL
.	NULL

Rayter	NULL
,	NULL
S.I	NULL
.	NULL

,	NULL
M.	NULL
Woodrow	NULL
,	NULL
S.C.	NULL
Lucas	NULL
,	NULL
D.A	NULL
.	NULL

Cantrell	NULL
,	NULL
and	NULL
J	NULL
.	NULL

Downward	NULL
.	NULL

1992.	NULL
p21	NULL
``	NULL
``	NULL
mediates	NULL
control	NULL
of	NULL
IL-2	NULL
gene	NULL
promoter	NULL
function	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

11:4549-4556	NULL
.	NULL

Northrop	NULL
,	NULL
J.P.	NULL
,	NULL
S.N	NULL
.	NULL

Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.J	NULL
.	NULL

Thomas	NULL
,	NULL
LA	NULL
.	NULL

Tim-merman	NULL
,	NULL
G.P	NULL
.	NULL

Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NFAT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

369:497-498	NULL
.	NULL

Bland	NULL
,	NULL
M.M	NULL
.	NULL

,	NULL
R.S	NULL
.	NULL

Monroe	NULL
,	NULL
and	NULL
C.-A	NULL
.	NULL

Ohmstede	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
cDNA	NULL
sequence	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
Ca**/calmodulin-dependent	NULL
protein	NULL
kinase-Gr	NULL
from	NULL
human	NULL
brain	NULL
and	NULL
thymus	NULL
.	NULL

Gene	NULL
.	NULL

142:191-197	NULL
.	NULL

Billingsley	NULL
,	NULL
ML	NULL
.	NULL

,	NULL
KR	NULL
.	NULL

Pennypacker	NULL
,	NULL
C.G	NULL
.	NULL

Hoover	NULL
,	NULL
DJ	NULL
.	NULL

Brigati	NULL
,	NULL
and	NULL
RL	NULL
.	NULL

Kincaid	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
detection	NULL
and	NULL
quantification	NULL
of	NULL
calcineurin	NULL
and	NULL
calmodulin	NULL
binding	NULL
proteins	NULL
using	NULL
biotinylated	NULL
calmodulin	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

82:7585-7589.	NULL
de	NULL
Wet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
K.V	NULL
.	NULL

Wodd	NULL
,	NULL
M.	NULL
Deluca	NULL
,	NULL
D.R	NULL
.	NULL

Helinski	NULL
,	NULL
and	NULL
S.	NULL
Subramani	NULL
.	NULL

1987	NULL
.	NULL

Firefly	NULL
luciferase	NULL
gene	NULL
:	NULL
structure	NULL
and	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:725-737	NULL
.	NULL

Trede	NULL
,	NULL
N.S	NULL
.	NULL

,	NULL
T.	NULL
Chatila	NULL
,	NULL
and	NULL
R.S	NULL
.	NULL

Geha	NULL
.	NULL

1993	NULL
.	NULL

Activator	NULL
pro-tein-1	NULL
(	NULL
AP-1	NULL
)	NULL
is	NULL
stimulated	NULL
by	NULL
microbial	NULL
superantigens	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23:2129-2135	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Imagawa	NULL
,	NULL
R.	NULL
Chiu	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
R.J.	NULL
Imbra	NULL
,	NULL
HJ	NULL
.	NULL

Rahmsdorf	NULL
,	NULL
C.	NULL
Jonat	NULL
,	NULL
P.	NULL
Herrlich	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1987	NULL
.	NULL

Phorbol	NULL
ester-inducible	NULL
genes	NULL
contain	NULL
a	NULL
common	NULL
cis	NULL
element	NULL
recognized	NULL
by	NULL
a	NULL
TPA-modulated	NULL
trans-acting	NULL
factor	NULL
.	NULL

Cell	NULL
.	NULL

49	NULL
:	NULL
729-739	NULL
.	NULL

Bohmann	NULL
,	NULL
D.	NULL
,	NULL
T.J.	NULL
Bos	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
T.	NULL
Nishimura	NULL
,	NULL
P.K	NULL
.	NULL

Vogt	NULL
,	NULL
and	NULL
R.	NULL
Tijan	NULL
.	NULL

1987	NULL
.	NULL

Human	NULL
proto-oncogene	NULL
c-jun	NULL
encodes	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
with	NULL
structural	NULL
and	NULL
functional	NULL
properties	NULL
of	NULL
transcriptional	NULL
factor	NULL
AP-1	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

238:1386-1	NULL
392	NULL
.	NULL

33	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.G	NULL
.	NULL

McCaffrey	NULL
,	NULL
V.E	NULL
.	NULL

Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

356:801-804	NULL
.	NULL

Lee	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
M.	NULL
Gilman	NULL
.	NULL

1994	NULL
.	NULL

Dual	NULL
modes	NULL
of	NULL
control	NULL
of	NULL
c-fos	NULL
mRNA	NULL
induction	NULL
by	NULL
intracellular	NULL
calcium	NULL
in	NULL
T	NULL
cells	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4579-4587	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
during	NULL
stimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
.	NULL

77:727-736	NULL
.	NULL

Kyriakis	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
P.	NULL
Banerjee	NULL
,	NULL
E.	NULL
Nikolakaki	NULL
,	NULL
T.	NULL
Daai	NULL
,	NULL
E.A	NULL
.	NULL

Ru-bie	NULL
,	NULL
M.F	NULL
.	NULL

Ahmad	NULL
,	NULL
J.	NULL
Avruch	NULL
,	NULL
and	NULL
J.R.	NULL
Woodgett	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
subfamily	NULL
of	NULL
c-jun	NULL
kinases	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

369:156-160	NULL
.	NULL

Nghiem	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
Ollick	NULL
,	NULL
P.	NULL
Gardner	NULL
,	NULL
and	NULL
H.	NULL
Schulman	NULL
.	NULL

1994	NULL
.	NULL

Interleukin-2	NULL
transcriptional	NULL
block	NULL
by	NULL
the	NULL
multifunctional	NULL
Ca**/calmodulin	NULL
kinase	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

371:347-350	NULL
.	NULL

Hama	NULL
,	NULL
N.	NULL
,	NULL
F.	NULL
Paliogianni	NULL
,	NULL
BJ	NULL
.	NULL

Fessler	NULL
,	NULL
and	NULL
D.T	NULL
.	NULL

Boumpas	NULL
.	NULL

1995	NULL
.	NULL

Calcium/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
II	NULL
down-regulates	NULL
both	NULL
calcineurin	NULL
and	NULL
protein	NULL
kinase	NULL
C-mediated	NULL
pathways	NULL
for	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
:	NULL
1217-1222	NULL
.	NULL

Izquierdo	NULL
,	NULL
M.	NULL
,	NULL
S.J	NULL
.	NULL

Leevers	NULL
,	NULL
C.J	NULL
.	NULL

Marshall	NULL
,	NULL
and	NULL
D.	NULL
Cantrell	NULL
.	NULL

1993.	NULL
p21	NULL
``	NULL
couples	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
to	NULL
extracellu-lar	NULL
signal-regulated	NULL
kinase	NULL
2	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1199-1208	NULL
.	NULL

Crabtree	NULL
,	NULL
G.R	NULL
.	NULL

,	NULL
and	NULL
N.	NULL
Clipstone	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transmission	NULL
between	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
the	NULL
nucleus	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Annu	NULL
,	NULL
Rev	NULL
.	NULL

Biochem	NULL
.	NULL

63:1045-1076	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
1994	NULL
.	NULL

NF-AT-AP-1	NULL
and	NULL
Rel-bZIP	NULL
:	NULL
;	NULL
hybrid	NULL
vigor	NULL
112	NULL
42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48.	NULL
and	NULL
binding	NULL
under	NULL
the	NULL
influence	NULL
.	NULL

Cell	NULL
.	NULL

77:795-798	NULL
.	NULL

Castigli	NULL
,	NULL
E.	NULL
,	NULL
TA	NULL
.	NULL

Chatila	NULL
,	NULL
and	NULL
R.S	NULL
.	NULL

Geha	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
protein	NULL
of	NULL
the	NULL
AP-1	NULL
family	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:3284-3290	NULL
.	NULL

Flanagan	NULL
,	NULL
W.M	NULL
.	NULL

,	NULL
B.	NULL
Corthesy	NULL
,	NULL
R.J.	NULL
Bram	NULL
,	NULL
and	NULL
G.	NULL
Crabtree	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
association	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporine	NULL
A	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

352	NULL
:	NULL
803-807	NULL
.	NULL

Woodrow	NULL
,	NULL
M.	NULL
,	NULL
N.A	NULL
.	NULL

Clipstone	NULL
,	NULL
and	NULL
D.	NULL
Cantrell	NULL
.	NULL

1993.	NULL
p21	NULL
``	NULL
and	NULL
calcineurin	NULL
synergize	NULL
to	NULL
regulate	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1517-1522	NULL
.	NULL

Miranti	NULL
,	NULL
CK	NULL
.	NULL

,	NULL
D.D	NULL
.	NULL

Ginty	NULL
,	NULL
G.	NULL
Huang	NULL
,	NULL
T.	NULL
Chatila	NULL
,	NULL
and	NULL
M.	NULL
Greenberg	NULL
.	NULL

1995	NULL
.	NULL

Calcium	NULL
activates	NULL
serum	NULL
response	NULL
factor-dependent	NULL
transcription	NULL
by	NULL
a	NULL
ras	NULL
and	NULL
Elk-i-independent	NULL
mechanism	NULL
that	NULL
involves	NULL
a	NULL
CaM	NULL
kinase	NULL
.	NULL

Mol	NULL
.	NULL

Celff	NULL
.	NULL

Biol	NULL
15	NULL
:	NULL
3672-3684	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.G	NULL
.	NULL

,	NULL
L.	NULL
Luo	NULL
,	NULL
T.K	NULL
.	NULL

Kerppola	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
T.M	NULL
.	NULL

Bad-alian	NULL
,	NULL
A.M.	NULL
Ho	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
W.S	NULL
.	NULL

Lane	NULL
,	NULL
J.N	NULL
.	NULL

Lambert	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

262	NULL
;	NULL
750-754	NULL
.	NULL

Ho	NULL
,	NULL
SN	NULL
.	NULL

,	NULL
D.J	NULL
.	NULL

Thomas	NULL
,	NULL
T.A	NULL
.	NULL

Luika	NULL
,	NULL
X.	NULL
Li	NULL
,	NULL
U.	NULL
Francke	NULL
,	NULL
and	NULL
G.R	NULL
.	NULL

Crabtree	NULL
.	NULL

1995	NULL
.	NULL

NFATc3	NULL
,	NULL
a	NULL
lymphoid-specific	NULL
NFAT	NULL
'	NULL
c	NULL
family	NULL
member	NULL
that	NULL
is	NULL
Ca**-regulated	NULL
and	NULL
exhibits	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificities	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:19898-19907	NULL
.	NULL

Masuda	NULL
,	NULL
E.S	NULL
.	NULL

,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
F.	NULL
Saito	NULL
,	NULL
C.	NULL
Hannum	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1995	NULL
.	NULL

NFAT	NULL
'	NULL
x	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
family	NULL
that	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2697-2706	NULL
.	NULL

Ca*+*	NULL
Signaling	NULL
Pathways	NULL
in	NULL
T	NULL
Lymphocytes	NULL

